Operating profit Q1–4/2025 | Net interest income Q1–4/2025 | Total income Q1–4/2025 | Total expenses Q1–4/2025 | CET1 ratio 31 Dec 2025 |
€559 million | +9% | +8% | +3% | 14.1 |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Operating profit (loss), € million | 559 | 473 | 18.0 |
Corporate Banking and Capital Markets | 343 | 307 | 11.7 |
Asset and Sales Finance Services and Payment Transfers | 184 | 167 | 9.9 |
Baltics | 38 | 39 | -3.0 |
Group Functions | -7 | -40 | — |
Total income | 833 | 773 | 7.8 |
Total expenses | -306 | -298 | 2.8 |
Cost/income ratio, %* | 36.8 | 38.6 | -1.8 |
Return on equity (ROE), %* | 8.6 | 7.9 | 0.8 |
Return on assets (ROA), %* | 0.58 | 0.48 | 0.09 |
31 Dec 2025 | 31 Dec 2024 | Change, % | |
CET1 ratio, %* | 14.1 | 14.1 | -0.1 |
Loan portfolio, € million | 29,079 | 28,295 | 2.8 |
Guarantee portfolio, € million | 2,662 | 2,660 | 0.1 |
Other exposures, € million | 5,579 | 5,238 | 6.5 |
Deposits, € million | 16,987 | 17,155 | -1.0 |
Ratio of non-performing exposures to exposures, %* | 1.4 | 1.8 | -0.4 |
Ratio of impairment loss on receivables to loan and guarantee portfolio, %* | -0.10 | 0.00 | -0.10 |
Other information about OP Corporate Bank | |
Financial indicators | |
Financial statements | |
Notes |
Income statement, € million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income* | 576 | 529 | 8.8 |
Impairment loss on receivables | 32 | -1 | — |
Net commissions and fees | 75 | 75 | 0.8 |
Investment income* | 131 | 136 | -3.5 |
Other operating income | 51 | 33 | 53.8 |
Personnel costs | -91 | -90 | 1.0 |
Depreciation/amortisation and impairment loss | -1 | -1 | -22.8 |
Other operating expenses | -215 | -207 | 3.7 |
Operating profit | 559 | 473 | 18.0 |
Risk exposure amount (REA) | 31 Dec 2025 | Share of REA, % | 31 Dec 2024 | Share of REA, % | Change, % |
Credit and counterparty risk | 32.1 | 89.8 | 29.5 | 89.4 | 9.1 |
Market risk | 1.1 | 3.1 | 1.2 | 3.5 | -4.7 |
Operational risk | 1.3 | 3.7 | 1.2 | 3.7 | 8.9 |
Other risks | 1.2 | 3.4 | 1.1 | 3.3 | 9.8 |
Total | 35.8 | 100.0 | 32.9 | 100.0 | 8.6 |
Rating agency | Short-term debt | Outlook | Long-term debt | Outlook |
Standard & Poor's | A-1+ | — | AA- | Stable |
Moody's | P-1 | Stable | Aa3 | Stable |
Performing forborne exposures (gross) | Non-performing exposures (gross) | Doubtful receivables (gross) | Loss allowance | Doubtful receivables (net) | ||||||
€ million | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2025 | 31 Dec 2024 |
More than 90 days past due | 60 | 59 | 60 | 59 | 29 | 34 | 31 | 25 | ||
Unlikely to be paid | 213 | 278 | 213 | 278 | 49 | 61 | 164 | 218 | ||
Forborne exposures | 749 | 806 | 233 | 302 | 982 | 1,109 | 77 | 95 | 906 | 1,014 |
Total | 749 | 806 | 506 | 640 | 1,255 | 1,446 | 154 | 190 | 1,101 | 1,256 |
OP Corporate Bank | ||
Key ratios | 31 Dec 2025 | 31 Dec 2024 |
Ratio of doubtful receivables to exposures, % | 3.35 | 4.00 |
Ratio of non-performing exposures to exposures, % | 1.35 | 1.76 |
Ratio of performing forborne exposures to exposures, % | 2.00 | 2.22 |
Ratio of performing forborne exposures to doubtful receivables, % | 59.67 | 55.77 |
Ratio of loss allowance (receivables from customers) to doubtful receivables, % | 20.04 | 20.45 |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Deposits with central banks | 15.5 | 17.9 | -13.5% |
Notes and bonds eligible as collateral | 15.5 | 12.3 | 26.3% |
Loan receivables eligible as collateral | 1.0 | 1.0 | -2.0% |
Total | 32.0 | 31.2 | 2.6% |
Receivables ineligible as collateral | 0.9 | 0.8 | 19.8% |
Liquidity buffer at market value | 32.9 | 32.0 | 3.0% |
Collateral haircut | -0.8 | -0.7 | 12.1% |
Liquidity buffer at collateral value | 32.1 | 31.2 | 2.8% |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income** | 317 | 279 | 13.4 |
Impairment loss on receivables | 20 | 6 | 261.7 |
Net commissions and fees | 9 | 6 | 55.3 |
Investment income** | 119 | 131 | -9.1 |
Other operating income | 7 | 6 | 16.8 |
Personnel costs | -39 | -39 | 1.0 |
Depreciation/amortisation and impairment loss | 0 | 0 | 8.8 |
Other operating expenses | -89 | -81 | 9.9 |
Operating profit | 343 | 307 | 11.7 |
Total income | 451 | 422 | 7.1 |
Total expenses | -128 | -120 | 7.0 |
Cost/income ratio, % | 28.4 | 28.5 | 0.0* |
Return on assets (ROA), % | 1.33 | 1.16** | 0.16* |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Loan portfolio | 17.2 | 16.7 | 2.9 |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income | 218 | 216 | 0.7 |
Impairment loss on receivables | 9 | -9 | — |
Net commissions and fees | 60 | 61 | -2.0 |
Investment income | 0 | 0 | -18.3 |
Other operating income | 17 | 19 | -9.7 |
Personnel costs | -34 | -33 | 2.4 |
Depreciation/amortisation and impairment loss | 0 | -1 | -55.3 |
Other operating expenses | -85 | -85 | 0.2 |
Operating profit | 184 | 167 | 9.9 |
Total income | 294 | 296 | -0.5 |
Total expenses | -119 | -119 | 0.5 |
Cost/income ratio, % | 40.6 | 40.2 | 0.4* |
Return on assets (ROA), % | 1.63 | 1.49 | 0.14* |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Loan portfolio | 8.6 | 8.7 | -1.1 |
Deposits | 14.0 | 13.8 | 1.8 |
€ million | Q1–4/2025 | Q1–4/2025 | Change, % |
Net interest income | 62 | 59 | 6.2 |
Impairment loss on receivables | 3 | 3 | -17.5 |
Net commissions and fees | 11 | 11 | -1.3 |
Other operating income | 1 | 1 | 10.1 |
Personnel costs | -12 | -12 | -0.7 |
Depreciation/amortisation and impairment loss | -1 | -1 | 12.8 |
Other operating expenses | -26 | -22 | 19.4 |
Operating profit | 38 | 39 | -3.0 |
Total income | 74 | 70 | 5.1 |
Total expenses | -39 | -35 | 12.2 |
Cost/income ratio, % | 52.3 | 49.1 | 3.3* |
Return on assets (ROA), % | 0.98 | 1.09 | -0.10* |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Loan portfolio | 3.3 | 2.9 | 13.8 |
Deposits | 1.9 | 1.7 | 10.8 |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income | 17 | 17 | 0.5 |
Impairment loss on receivables | 1 | 0 | — |
Net commissions and fees | 3 | 2 | 9.9 |
Other operating income | 0 | 0 | 23.6 |
Personnel costs | -4 | -4 | -2.6 |
Depreciation/amortisation and impairment loss | 0 | 0 | 7.7 |
Other operating expenses | -8 | -7 | 10.6 |
Operating profit | 10 | 9 | 5.1 |
Total income | 20 | 20 | 1.9 |
Total expenses | -12 | -11 | 6.0 |
Cost/income ratio, % | 57.5 | 55.3 | 2.2* |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Loan portfolio | 0.9 | 0.8 | 8.4 |
Deposits | 0.6 | 0.5 | 21.6 |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income | 18 | 16 | 13.4 |
Impairment loss on receivables | 2 | 6 | — |
Net commissions and fees | 3 | 3 | -1.6 |
Other operating income | 0 | 0 | 5.5 |
Personnel costs | -3 | -4 | -7.4 |
Depreciation/amortisation and impairment loss | 0 | 0 | 28.1 |
Other operating expenses | -9 | -8 | 19.8 |
Operating profit | 10 | 13 | -21.7 |
Total income | 21 | 19 | 10.8 |
Total expenses | -13 | -11 | 10.9 |
Cost/income ratio, % | 60.4 | 60.3 | 0.1* |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Loan portfolio | 0.7 | 0.7 | 8.2 |
Deposits | 0.7 | 0.6 | 18.7 |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income | 27 | 26 | 5.8 |
Impairment loss on receivables | 0 | -2 | — |
Net commissions and fees | 5 | 5 | -6.1 |
Other operating income | 0 | 0 | 4.8 |
Personnel costs | -5 | -5 | 5.8 |
Depreciation/amortisation and impairment loss | 0 | 0 | 10.9 |
Other operating expenses | -10 | -7 | 35.1 |
Operating profit | 18 | 17 | 4.0 |
Total income | 33 | 32 | 3.8 |
Total expenses | -15 | -12 | 23.1 |
Cost/income ratio, % | 43.9 | 38.2 | 5.8* |
€ billion | 31 Dec 2025 | 31 Dec 2024 | Change, % |
Loan portfolio | 1.7 | 1.4 | 20.5 |
Deposits | 0.6 | 0.6 | -6.0 |
€ million | Q1–4/2025 | Q1–4/2024 | Change, % |
Net interest income | -21 | -25 | -16.6 |
Impairment loss on receivables | 0 | -1 | — |
Net commissions and fees | -4 | -3 | 43.4 |
Investment income | 12 | 5 | 129.1 |
Other operating income | 44 | 22 | 95.2 |
Personnel costs | -6 | -6 | -2.6 |
Depreciation/amortisation and impairment loss | 0 | 0 | -7.8 |
Other operating expenses | -32 | -34 | -5.5 |
Operating profit (loss) | -7 | -40 | — |
Receivables and liabilities from/to the amalgamation's central cooperative and affiliated credit institutions, net position, € billion* | -18.8 | -16.4 | 15.0 |
31 Dec 2025 | 31 Dec 2024 | |
Corporate Banking and Capital Markets | 304 | 298 |
Asset and Sales Finance Services and Payment Transfers | 388 | 371 |
Baltics | 165 | 158 |
Group Functions | 52 | 52 |
Total | 909 | 879 |
Adjusted | |||
Key income statement items, € million | 2025 | 2024 | 2023 |
Net interest income | 576 | 529 | 582 |
Impairment loss on receivables | 32 | -1 | -96 |
Net commissions and fees | 75 | 75 | 73 |
Investment income | 131 | 136 | 52 |
Other income | 51 | 33 | 31 |
Personnel costs | -91 | -90 | -84 |
Other expenses | -215 | -208 | -229 |
Operating profit | 559 | 473 | 329 |
Key balance sheet items – assets, € million | 2025 | 2024 | 2023 |
Cash and deposits with central banks | 15,769 | 18,071 | 19,710 |
Receivables from credit institutions | 10,486 | 10,753 | 12,280 |
Receivables from customers | 29,181 | 28,385 | 28,187 |
Derivative contracts | 2,544 | 3,383 | 4,445 |
Investment assets | 17,627 | 14,234 | 12,823 |
Property, plant and equipment, and intangible assets | 9 | 6 | 4 |
Other items | 643 | 850 | 695 |
Total assets | 76,259 | 75,683 | 78,145 |
Key balance sheet items – liabilities and equity, € million | 2025 | 2024 | 2023 |
Liabilities to credit institutions | 27,745 | 25,049 | 23,982 |
Liabilities to customers | 19,722 | 19,387 | 17,254 |
Derivative contracts | 2,647 | 3,150 | 4,179 |
Debt securities issued to the public | 17,199 | 19,326 | 24,062 |
Other liabilities | 3,691 | 3,905 | 4,071 |
Equity capital | 5,255 | 4,866 | 4,597 |
Total liabilities and equity | 76,259 | 75,683 | 78,145 |
Adjusted | ||||||
€ million | Q1/2025 | Q2/2025 | Q3/2025 | Q4/2025 | Q1–4/2025 | Q1–4/2024 |
Net interest income | 157 | 147 | 141 | 149 | 576 | 529 |
Impairment loss on receivables | -1 | 27 | 13 | -7 | 32 | -1 |
Net commissions and fees | 17 | 17 | 18 | 24 | 75 | 75 |
Investment income | 24 | 30 | 31 | 28 | 131 | 136 |
Other operating income | 17 | 13 | 10 | 10 | 51 | 33 |
Personnel costs | -21 | -23 | -22 | -24 | -91 | -90 |
Depreciation/amortisation and impairment loss | 0 | 0 | 0 | 0 | -1 | -1 |
Other operating expenses | -52 | -50 | -49 | -64 | -215 | -207 |
Operating profit | 140 | 160 | 141 | 117 | 559 | 473 |
Earnings before tax | 140 | 160 | 141 | 117 | 559 | 473 |
Income tax | -28 | -32 | -29 | -33 | -121 | -101 |
Profit for the period | 112 | 129 | 113 | 84 | 437 | 372 |
2025 | 2024 | 2023 | |
Return on equity (ROE), % | 8.6 | 7.9 | 5.9 |
Return on equity at fair value (ROE), % | 9.9 | 7.3 | 5.2 |
Return on assets (ROA), % | 0.58 | 0.48 | 0.30 |
Equity ratio, % | 6.9 | 6.4 | 5.9 |
Cost/income ratio, % | 36.8 | 38.6 | 42.4 |
Average personnel | 905 | 905 | 862 |
Share-related figures and ratios | |||
Equity per share, € | 16.44 | 15.23 | 14.38 |
Dividend per share, €* | 0.41 | 0.35 | 0.24 |
Dividend payout ratio, %* | 29.95 | 30.08 | 28.68 |
Number of shares, financial year end | 319,551,415 | 319,551,415 | 319,551,415 |
Return on equity (ROE), % | Financial performance for the reporting period x (days of financial year/days of reporting period) | x 100 | The ratio describes how much return is generated on equity capital as a percentage of equity during the reporting period. |
Equity capital (average at beginning and end of period) | |||
Return on equity at fair value (ROE), % | Total comprehensive income for the financial year | x 100 | The ratio describes how much return is generated on equity capital on the basis of comprehensive income during the financial year. |
Equity capital (average at beginning and end of period) | |||
Return on assets (ROA), % | Financial performance for the reporting period x (days of financial year/days of reporting period) | x 100 | The ratio describes how much return is generated on capital tied up on business during the reporting period. |
Average balance sheet total (average at beginning and end of period) | |||
Equity ratio, % | Equity capital | x 100 | The ratio describes what proportion of the company's assets is equity capital. |
Balance sheet total | |||
Equity per share | Equity capital | The ratio describes shareholders' equity per share. | |
Share-issue adjusted number of shares on the balance sheet date | |||
Dividend per share, € | Dividends paid for the financial year | Dividend per share describes the ratio of dividend to each share. | |
Share-issue adjusted number of shares on the balance sheet date | |||
Dividend payout ratio, % | Dividend per share | x 100 | The dividend payout ratio describes the proportion of dividend to earnings for the financial year. |
Earnings per share |
Total income | Net interest income + Net commissions and fees + Investment income + Other operating income | The figure describes the development of all income. | |
Total expenses | Personnel costs + Depreciation/amortisation and impairment loss + Other operating expenses | The figure describes the development of all expenses. | |
Cost/income ratio, % | Total expenses | x 100 | The ratio describes the ratio of expenses to income. The lower that ratio, the better. |
Total income | |||
Investment income | Net interest income from financial assets held for trading + Net investment income | The figure describes the development of all income related to investment. | |
Loan portfolio | Loans and loss allowance included in the balance sheet item Receivables from customers. The loan portfolio does not include interest not received or valuation items related to derivatives. | Total amount of loans granted to customers. |
Ratio of impairment loss on receivables to loan and guarantee portfolio, % | Impairment loss on receivables x (days of financial year/days of reporting period) | x 100 | The ratio describes the ratio of impairment loss on receivables entered in the income statement to the loan and guarantee portfolio. The lower that ratio, the better. |
Loan and guarantee portfolio at period end | |||
Deposits | Deposits included in balance sheet item Liabilities to customers. Deposits do not include unpaid interest or valuation items related to derivatives. | Total amount of deposits by customers. | |
Coverage ratio, % | Loss allowance | x 100 | The ratio describes how much the amount of expected losses covers the amount of the liability. |
Balance sheet items involving credit risk + Credit equivalent of off-balance-sheet items |
Default capture rate, % | New defaulted contracts in stage 2 a year ago | x 100 | The ratio describes the effectiveness of the SICR model (significant increase in credit risk), in other words how many contracts were in stage 2 before moving to stage 3. |
New defaulted contracts during the reporting period |
Capital adequacy ratio, % | Total own funds | x 100 | The ratio describes a credit institution's capital adequacy and shows the ratio of own funds to the total risk exposure amount. |
Total risk exposure amount | |||
Tier 1 ratio, % | Tier 1 capital | x 100 | The ratio describes a credit institution's capital adequacy and shows the ratio of Tier 1 capital to the total risk exposure amount. |
Total risk exposure amount | |||
Common Equity Tier 1 (CET1) capital ratio, % | CET1 capital | x 100 | The ratio describes a credit institution's capital adequacy and shows the ratio of CET1 capital to the total risk exposure amount. |
Total risk exposure amount | |||
Leverage ratio, % | Tier 1 capital (T1) | x 100 | The ratio describes a credit institution's indebtedness and shows the ratio of Tier 1 capital to the total risk exposure amount. |
Exposure amount |
Liquidity coverage requirement (LCR), % | Liquid assets | x 100 | The ratio describes short-term funding liquidity risk that requires the bank to have sufficient, high-quality liquid assets to get through an acute 30-day stress scenario. |
Liquidity outflows – Liquidity inflows under stressed conditions | |||
Net stable funding ratio (NSFR), % | Available stable funding | x 100 | The ratio describes a long-term liquidity risk that requires the bank to have a sufficient amount of stable funding sources in relation to items requiring stable funding sources. The objective is to secure the sustainable maturity structure of assets and liabilities applying a 12-month time horizon and to restrict excessive resort to short-term wholesale funding. |
Required stable funding |
Non-performing exposures % of exposures | Non-performing exposures (gross) | x 100 | The ratio describes the ratio of customers with severe payment difficulties to the entire exposure portfolio. Non-performing exposures refer to receivables that are more than 90 days past due and other receivables classified as risky as well as forborne exposures related to such receivables due to the customer's financial difficulties. Forbearance measures consist of concessions, agreed on the customer's initiative, regarding the original repayment plan to enable the customer to surmount temporary payment difficulties. Non- performing exposures are presented in gross terms; expected credit losses have not been deducted from them. |
Exposures at period end | |||
Ratio of doubtful receivables to exposures, % | Doubtful receivables (gross) | x 100 | The ratio describes the ratio of customers with payment difficulties to the entire exposure portfolio. Doubtful receivables refer to receivables that are more than 90 days past due and other receivables classified as risky, as well as forbearance related to such receivables or to performing receivables due to the customer's financial difficulties. Forbearance measures consist of concessions, agreed on the customer's initiative, regarding the original repayment plan to enable the customer to surmount temporary payment difficulties. In addition to non-performing forborne exposures, doubtful receivables include non-performing exposures reclassified as performing ones during their probation period or forbearance measures made into a performing agreement. Loan modifications due to reasons other than the customer's financial difficulties are not classified as doubtful receivables. Doubtful receivables are presented in gross terms; expected credit losses have not been deducted from them. |
Exposures at period end |
Ratio of performing forborne exposures to exposures, % | Performing forborne exposures (gross) | x 100 | The ratio describes the ratio of forborne exposures to the entire exposure portfolio. Performing forborne exposures include forborne exposures reclassified as performing ones during their probation period or forbearance measures made into a performing agreement. Loan modifications due to reasons other than the customer's financial difficulties are not classified as forborne exposures. |
Exposures at period end |
Ratio of performing forborne exposures to doubtful receivables, % | Performing forborne exposures (gross) | x 100 | The ratio describes the ratio of performing forborne exposures to doubtful receivables that include non-performing exposures as well as performing forborne exposures. Performing forborne exposures include forborne exposures reclassified as performing ones during their probation period or forbearance measures made into a performing agreement. Loan modifications due to reasons other than the customer's financial difficulties are not classified as forborne exposures. |
Doubtful receivables at period end | |||
Ratio of loss allowance (receivables from customers) to doubtful receivables, % | Loss allowance for receivables from customers in the balance sheet | x 100 | The ratio describes the ratio of expected losses to all doubtful receivables. Doubtful receivables include non-performing exposures and performing forborne exposures. |
Doubtful receivables at period end |
Loan and guarantee portfolio | Loan portfolio + guarantee portfolio | The indicator describes the total amount of loans and guarantees given. |
Exposures | Loan and guarantee portfolio + interest receivables + unused standby credit facilities | The sum of the loan and guarantee portfolio, interest receivables and unused standby credit facilities (undrawn loans and limits) is used as the basis for proportioning doubtful receivables and non-performing exposures. | |
Other exposures | Interest receivables + unused standby credit facilities | In addition to the loan and guarantee portfolio, exposures come from interest receivables and unused standby credit facilities (undrawn loans and limits). |
€ million | 31 Dec 2025 | 31 Dec 2024 |
OP Corporate Bank plc's equity | 5,255 | 4,866 |
Fair value reserve, cash flow hedge | 1 | 0 |
Common Equity Tier 1 (CET1) before deductions | 5,256 | 4,866 |
Intangible assets | -5 | -3 |
Excess funding of pension liability and valuation adjustments | -57 | -51 |
Planned profit distribution | -131 | -112 |
Insufficient coverage for non-performing exposures | -32 | -43 |
CET1 capital | 5,030 | 4,658 |
Tier 1 capital (T1) | 5,030 | 4,658 |
Debenture loans | 796 | 1,288 |
Debentures to which transition rules apply | 0 | 22 |
General credit risk adjustments | 23 | 24 |
Tier 2 capital (T2) | 819 | 1,334 |
Total own funds | 5,849 | 5,992 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Credit and counterparty risk | 32,143 | 29,458 |
Standardised Approach (SA) | 32,143 | 29,458 |
Central government and central bank exposure | 34 | 106 |
Credit institution exposure | 650 | 524 |
Corporate exposure | 19,738 | 22,519 |
Retail exposure | 2,958 | 3,192 |
Mortgage-backed and real estate development exposure | 7,235 | 1,475 |
Defaulted exposure | 382 | 456 |
Items of especially high risk | 0 | 118 |
Covered bonds | 772 | 697 |
Collective investment undertakings (CIU) | 27 | 36 |
Equity investments | 0 | 3 |
Other | 346 | 330 |
Risks of the CCP's default fund | 1 | 1 |
Securitisations | 29 | 27 |
Market and settlement risk (Standardised Approach) | 861 | 944 |
Operational risk (Standardised Approach) | 1,339 | 1,229 |
Valuation adjustment (CVA) | 238 | 210 |
Other risks* | 1,181 | 1,075 |
Total risk exposure amount | 35,792 | 32,944 |
Ratios, % | 31 Dec 2025 | 31 Dec 2024 |
CET1 capital ratio | 14.1 | 14.1 |
Tier 1 capital ratio | 14.1 | 14.1 |
Capital adequacy ratio | 16.3 | 18.2 |
Capital requirement, € million | 31 Dec 2025 | 31 Dec 2024 |
Own funds | 5,849 | 5,992 |
Capital requirement | 3,907 | 3,547 |
Buffer for capital requirements | 1,942 | 2,445 |
Adjusted | |||
€ million | Note | 2025 | 2024 |
Interest income calculated using the effective interest method | 2,301 | 3,088 | |
Interest expenses | -1,725 | -2,559 | |
Net interest income | 4 | 576 | 529 |
Impairment loss on receivables | 5 | 32 | -1 |
Commission income | 133 | 131 | |
Commission expenses | -58 | -57 | |
Net commissions and fees | 6 | 75 | 75 |
Net income from financial assets held for trading | 7 | 130 | 136 |
Net investment income | 8 | 1 | 0 |
Other operating income | 9 | 51 | 33 |
Personnel costs | 10 | -91 | -90 |
Depreciation/amortisation and impairment loss | 11 | -1 | -1 |
Other operating expenses | 12 | -215 | -207 |
Operating expenses | -306 | -298 | |
Operating profit | 559 | 473 | |
Earnings before tax | 13 | 559 | 473 |
Income tax | -121 | -101 | |
Profit for the financial year | 437 | 372 |
€ million | Note | 2025 | 2024 |
Profit for the financial year | 437 | 372 | |
Items that will not be reclassified to profit or loss | |||
Gains/(losses) arising from remeasurement of defined benefit plans | 28 | 3 | 4 |
Changes in own credit risk on liabilities measured at fair value | -1 | -7 | |
Items that may be subsequently reclassified to profit or loss | |||
Change in fair value reserve | |||
On fair value measurement | 30 | 79 | -39 |
On cash flow hedging | 30 | -1 | 8 |
Income tax | |||
On items not reclassified to profit or loss | |||
On gains/(losses) arising from remeasurement of defined benefit plans | 24 | -1 | -1 |
Changes in own credit risk on liabilities measured at fair value | 0 | 1 | |
On items that may be subsequently reclassified to profit or loss | |||
On fair value measurement | 30 | -16 | 8 |
On cash flow hedging | 30 | 0 | -2 |
Other comprehensive income items | 64 | -27 | |
Total comprehensive income for the financial year | 501 | 345 |
€ million | Note | 31 Dec 2025 | 31 Dec 2024 |
Cash and deposits with central banks | 15 | 15,769 | 18,071 |
Receivables from credit institutions | 16 | 10,486 | 10,753 |
Receivables from customers | 17 | 29,181 | 28,385 |
Derivative contracts | 18 | 2,544 | 3,383 |
Investment assets | 19 | 17,627 | 14,234 |
Intangible assets | 20 | 5 | 3 |
Property, plant and equipment | 21 | 5 | 4 |
Other assets | 23 | 643 | 850 |
Total assets | 76,259 | 75,683 | |
Liabilities to credit institutions | 25 | 27,745 | 25,049 |
Liabilities to customers | 26 | 19,722 | 19,387 |
Derivative contracts | 18 | 2,647 | 3,150 |
Debt securities issued to the public | 27 | 17,199 | 19,326 |
Provisions and other liabilities | 28 | 2,548 | 2,142 |
Income tax liabilities | 24 | 13 | 23 |
Deferred tax liabilities | 24 | 319 | 295 |
Subordinated liabilities | 29 | 811 | 1,444 |
Total liabilities | 71,005 | 70,817 | |
Equity capital | 30 | ||
Share capital | 428 | 428 | |
Fair value reserve | -25 | -88 | |
Other reserves | 1,019 | 1,019 | |
Retained earnings | 3,833 | 3,507 | |
Total equity | 5,255 | 4,866 | |
Total liabilities and equity | 76,259 | 75,683 |
€ million | Share capital | Fair value reserve | Other reserves | Retained earnings | Total equity |
Equity capital 1 January 2024 | 428 | -63 | 1,019 | 3,213 | 4,597 |
Total comprehensive income for the financial year | -25 | 370 | 345 | ||
Profit for the financial year | 372 | 372 | |||
Other comprehensive income items | -25 | -2 | -27 | ||
Profit distribution | -76 | -76 | |||
Other | 0 | 0 | |||
Equity capital 31 December 2024 | 428 | -88 | 1,019 | 3,507 | 4,866 |
€ million | Share capital | Fair value reserve | Other reserves | Retained earnings | Total equity |
Equity capital 1 January 2025 | 428 | -88 | 1,019 | 3,507 | 4,866 |
Total comprehensive income for the financial year | 63 | 438 | 501 | ||
Profit for the financial year | 437 | 437 | |||
Other comprehensive income items | 63 | 1 | 64 | ||
Profit distribution | -112 | -112 | |||
Other | 0 | 0 | |||
Equity capital 31 December 2025 | 428 | -25 | 1,019 | 3,833 | 5,255 |
€ million | Note | 2025 | 2024 |
Cash flow from operating activities | |||
Profit for the financial year | 437 | 372 | |
Adjustments to profit for the financial year | 669 | 512 | |
Increase (-) or decrease (+) in operating assets | -3,042 | 605 | |
Receivables from credit institutions | 16 | 397 | 1,494 |
Receivables from customers | 17 | -756 | -151 |
Derivative contracts, assets | 18 | 404 | 639 |
Investment assets | 19 | -3,294 | -1,191 |
Other assets | 23 | 207 | -186 |
Increase (+) or decrease (–) in operating liabilities | 2,882 | 2,186 | |
Liabilities to credit institutions | 25 | 2,624 | 900 |
Liabilities to customers | 26 | 335 | 2,133 |
Derivative contracts, liabilities | 18 | -502 | -809 |
Provisions and other liabilities | 28 | 426 | -38 |
Income tax paid | -123 | -81 | |
Dividends received | 1 | 2 | |
A. Net cash from operating activities | 825 | 3,596 | |
Cash flow from investing activities | |||
Purchase of PPE and intangible assets | 20, 21 | -13 | -10 |
Proceeds from sale of PPE and intangible assets | 20, 21 | 10 | 7 |
B. Net cash used in investing activities | -3 | -3 | |
Cash flow from financing activities | |||
Increases in subordinated liabilities | 29 | 807 | 1 |
Decreases in subordinated liabilities | 29 | -1,456 | |
Increases in debt securities issued to the public | 27 | 8,733 | 7,865 |
Decreases in debt securities issued to the public | 27 | -11,066 | -13,043 |
Dividends paid | -112 | -76 | |
Lease liabilities | 22 | -1 | -1 |
C. Net cash used in financing activities | -3,095 | -5,254 | |
Net change in cash and cash equivalents (A+B+C) | -2,273 | -1,661 |
€ million | Note | 2025 | 2024 |
Cash and cash equivalents at financial year start | 18,222 | 19,894 | |
Effect of foreign exchange rate changes | 101 | -11 | |
Cash and cash equivalents at financial year end | 16,050 | 18,222 | |
Interest received | 4,739 | 6,085 | |
Interest paid | -4,039 | -5,296 | |
Adjustments to profit for the period | |||
Non-cash items and other adjustments | |||
Impairment loss on receivables | -32 | 2 | |
Changes in value of financial instruments | 470 | 191 | |
Defined benefit pension plans | 0 | 0 | |
Depreciation/amortisation and impairment loss | 1 | 1 | |
Income tax paid | 121 | 101 | |
Other | 109 | 216 | |
Total adjustments | 669 | 512 | |
Cash and cash equivalents | |||
Cash and deposits with central banks | 15,769 | 18,071 | |
Receivables from credit institutions payable on demand | 281 | 151 | |
Total | 16,050 | 18,222 |
Note 31. Loss allowance regarding receivables and notes and bonds | 117 |
Earnings January–December 2025, € million | Corporate Banking and Capital Markets | Asset and Sales Finance Services and Payment Transfers | Baltics | Group Functions | Inter- segment items | Total |
Interest income calculated using the effective interest method | 862 | 767 | 180 | 1,985 | -1,493 | 2,301 |
Interest expenses | -545 | -550 | -118 | -2,005 | 1,493 | -1,725 |
Net interest income | 317 | 218 | 62 | -21 | 0 | 576 |
of which inter-segment items | -302 | 119 | -35 | 219 | 0 | 0 |
Impairment loss on receivables | 20 | 9 | 3 | 0 | 0 | 32 |
Commission income | 57 | 65 | 11 | 0 | 0 | 133 |
Commission expenses | -48 | -5 | 0 | -5 | 0 | -58 |
Net commissions and fees | 9 | 60 | 11 | -4 | 0 | 75 |
Net income from financial assets held for trading | 119 | 0 | 0 | 11 | 0 | 130 |
Net investment income | 0 | 0 | 0 | 1 | 0 | 1 |
Other operating income | 7 | 17 | 1 | 44 | -18 | 51 |
Personnel costs | -39 | -34 | -12 | -6 | 0 | -91 |
Depreciation/amortisation and impairment loss | 0 | 0 | -1 | 0 | 0 | -1 |
Other operating expenses | -89 | -85 | -26 | -32 | 18 | -215 |
Operating expenses | -128 | -119 | -39 | -38 | 18 | -306 |
Operating profit (loss) | 343 | 184 | 38 | -7 | 0 | 559 |
Earnings before tax | 343 | 184 | 38 | -7 | 0 | 559 |
Earnings January–December 2024, € million | Corporate Banking and Capital Markets | Asset and Sales Finance Services and Payment Transfers | Baltics | Group Functions | Intersegment items | Total |
Interest income calculated using the effective interest method | 1,123 | 905 | 217 | 2,780 | -1,938 | 3,088 |
Interest expenses | -844 | -689 | -158 | -2,805 | 1,938 | -2,559 |
Net interest income | 279 | 216 | 59 | -25 | 0 | 529 |
of which inter-segment items | -510 | 185 | -45 | 370 | 0 | |
Impairment loss on receivables | 6 | -9 | 3 | -1 | 0 | -1 |
Commission income | 54 | 67 | 11 | 0 | 0 | 131 |
Commission expenses | -48 | -6 | 0 | -3 | 0 | -57 |
Net commissions and fees | 6 | 61 | 11 | -3 | 0 | 75 |
Net income from financial assets held for trading | 130 | 0 | 0 | 6 | 0 | 136 |
Net investment income | 0 | 0 | 0 | 0 | 0 | 0 |
Other operating income | 6 | 19 | 1 | 22 | -15 | 33 |
Personnel costs | -39 | -33 | -12 | -6 | 0 | -90 |
Depreciation/amortisation and impairment loss | 0 | -1 | -1 | 0 | 0 | -1 |
Other operating expenses | -81 | -85 | -22 | -34 | 15 | -207 |
Operating expenses | -120 | -119 | -35 | -40 | 15 | -298 |
Operating profit (loss) | 307 | 167 | 39 | -40 | 0 | 473 |
Earnings before tax | 307 | 167 | 39 | -40 | 0 | 473 |
Balance sheet 31 December 2025, € million | Corporate Banking and Capital Markets | Asset and Sales Finance Services and Payment Transfers | Baltics | Group Functions | Total |
Cash and deposits with central banks | 0 | 134 | 16 | 15,619 | 15,769 |
Receivables from credit institutions | 0 | 186 | 0 | 10,300 | 10,486 |
Receivables from customers | 17,287 | 8,609 | 3,294 | -9 | 29,181 |
Derivative contracts | 2,530 | 0 | 0 | 14 | 2,544 |
Investment assets | 690 | 0 | 0 | 16,938 | 17,627 |
Intangible assets | 2 | 0 | 0 | 2 | 5 |
Property, plant and equipment | 0 | 2 | 2 | 1 | 5 |
Other assets | 254 | 47 | 4 | 337 | 643 |
Total assets | 20,763 | 8,976 | 3,317 | 43,203 | 76,259 |
Liabilities to credit institutions | 0 | 13 | 0 | 27,732 | 27,745 |
Liabilities to customers | 67 | 13,732 | 1,910 | 4,013 | 19,722 |
Derivative contracts | 2,518 | 0 | 0 | 129 | 2,647 |
Debt securities issued to the public | 1,789 | 0 | 0 | 15,410 | 17,199 |
Provisions and other liabilities | 102 | 1,476 | 155 | 814 | 2,548 |
Income tax liabilities | 0 | 0 | 3 | 10 | 13 |
Deferred tax liabilities | 0 | 0 | 0 | 319 | 319 |
Subordinated liabilities | 0 | 0 | 0 | 811 | 811 |
Total liabilities | 4,476 | 15,221 | 2,068 | 49,240 | 71,005 |
Equity capital | 5,255 |
Balance sheet 31 December 2024, € million | Corporate Banking and Capital Markets | Asset and Sales Finance Services and Payment Transfers | Baltics | Group Functions | Total |
Cash and deposits with central banks | 0 | 168 | 19 | 17,883 | 18,071 |
Receivables from credit institutions | 0 | 148 | 1 | 10,604 | 10,753 |
Receivables from customers | 16,821 | 8,712 | 2,866 | -13 | 28,385 |
Derivative contracts | 3,276 | 0 | 0 | 108 | 3,383 |
Investment assets | 515 | 0 | 0 | 13,719 | 14,234 |
Intangible assets | 1 | 0 | 0 | 2 | 3 |
Property, plant and equipment | 0 | 1 | 2 | 1 | 4 |
Other assets | 28 | 47 | 12 | 762 | 850 |
Total assets | 20,641 | 9,077 | 2,900 | 43,065 | 75,683 |
Liabilities to credit institutions | 0 | 32 | 0 | 25,017 | 25,049 |
Liabilities to customers | 74 | 13,497 | 1,696 | 4,120 | 19,387 |
Derivative contracts | 3,009 | 0 | 0 | 140 | 3,150 |
Debt securities issued to the public | 2,160 | 0 | 0 | 17,167 | 19,326 |
Provisions and other liabilities | 23 | 850 | 28 | 1,241 | 2,142 |
Income tax liabilities | 0 | 0 | 2 | 21 | 23 |
Deferred tax liabilities | 0 | 0 | 0 | 295 | 295 |
Subordinated liabilities | 0 | 0 | 0 | 1,444 | 1,444 |
Total liabilities | 5,266 | 14,379 | 1,727 | 49,446 | 70,817 |
Equity capital | 4,866 |
Adjusted | ||
€ million | 2025 | 2024 |
Interest income | ||
Interest income calculated using the effective interest method | ||
Interest income on receivables from credit institutions | 693 | 1,031 |
Interest income on loans to customers | 1,049 | 1,299 |
Interest income on finance lease receivables | 96 | 112 |
Interest income on notes and bonds measured at amortised cost | 67 | 56 |
Interest income on liabilities to customers | 0 | 0 |
Interest income on notes and bonds measured at fair value through profit or loss | 0 | 0 |
Interest income on notes and bonds measured at fair value through other comprehensive income | 225 | 165 |
Interest income on derivative contracts, fair value hedges | 137 | 30 |
Interest income on derivative contracts, cash flow hedges | 0 | 61 |
Other interest income on derivative contracts | 0 | 0 |
Interest income on loans to customers, fair value adjustments in hedge accounting | 18 | 30 |
Interest income on notes and bonds, fair value adjustments in hedge accounting | -8 | 247 |
Other interest income | 23 | 56 |
Total | 2,301 | 3,088 |
Adjusted | ||
€ million | 2025 | 2024 |
Interest expenses | ||
Liabilities to credit institutions | ||
Interest expenses for deposits to credit institutions | -581 | -752 |
Interest expenses for liabilities to credit institutions | 0 | 0 |
Interest expenses for liabilities to credit institutions, fair value adjustments in hedge accounting | -72 | -167 |
Liabilities to customers | ||
Interest expenses for deposits to customers | -323 | -461 |
Interest expenses for other liabilities to customers | -82 | -81 |
Debt securities issued to the public | ||
Interest expenses on debt securities issued to the public | -391 | -489 |
Interest expenses on debt securities issued to the public, fair value adjustments in hedge accounting | -116 | -222 |
Subordinated liabilities | ||
Interest expenses for perpetual and debenture loans | -36 | -38 |
Interest expenses for subordinated liabilities, fair value adjustments in hedge accounting | -7 | -30 |
Derivative contracts | ||
Interest expenses for derivative contracts, fair value hedges | -59 | -163 |
Interest expenses for derivative contracts, cash flow hedges | 11 | 24 |
Interest expenses for other derivative contracts | -33 | -103 |
Receivables from credit institutions | ||
Negative interest | 0 | 0 |
Other interest expenses | -34 | -76 |
Total | -1,725 | -2,559 |
Total net interest income | 576 | 529 |
€ million | 2025 | 2024 |
Receivables written down as loan and guarantee losses | -14 | -29 |
Recoveries of receivables written down | 1 | 1 |
Expected credit losses (ECL) on receivables from customers and off-balance-sheet items | 44 | 29 |
Expected credit losses (ECL) on notes and bonds | 2 | -2 |
Total impairment loss on receivables | 32 | -1 |
Corporate Banking and Capital Markets | Asset and Sales Finance Services and Payment Transfers | Baltics | Group Functions | Total | ||||||
€ million | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
Commission income | ||||||||||
Lending | 23 | 24 | 23 | 22 | 4 | 3 | 0 | 0 | 50 | 50 |
Deposits | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 2 | 3 |
Payment transfers | 0 | 0 | 32 | 32 | 1 | 1 | 0 | 0 | 32 | 32 |
Securities brokerage | 23 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 23 | 18 |
Securities issuance | 6 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 7 |
Mutual funds | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wealth management | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 3 |
Legal services | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Guarantees | 1 | 1 | 7 | 7 | 4 | 4 | 0 | 0 | 12 | 12 |
Other | 0 | 0 | 2 | 5 | 1 | 0 | 0 | 0 | 3 | 5 |
Total | 57 | 54 | 65 | 67 | 11 | 11 | 0 | 0 | 133 | 131 |
Corporate Banking and Capital Markets | Asset and Sales Finance Services and Payment Transfers | Baltics | Group Functions | Total | ||||||
€ million | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
Commission expenses | ||||||||||
Lending | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | -1 |
Payment transfers | -1 | -1 | -4 | -2 | 0 | 0 | -1 | 0 | -5 | -3 |
Securities brokerage | -2 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | -2 |
Securities issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wealth management | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 |
Derivatives | -41 | -41 | 0 | 0 | 0 | 0 | 0 | 0 | -41 | -41 |
Other | -3 | -3 | -1 | -3 | 0 | 0 | -3 | -2 | -7 | -8 |
Total | -48 | -48 | -5 | -6 | 0 | 0 | -5 | -3 | -58 | -57 |
Total net commissions and fees | 9 | 6 | 60 | 61 | 11 | 11 | -4 | -3 | 75 | 75 |
Adjusted | ||
€ million | 2025 | 2024 |
Notes and bonds | ||
Interest income and expenses | 21 | 13 |
Fair value gains and losses on notes and bonds | 1 | 2 |
Shares and participations | ||
Fair value gains and losses | 2 | 6 |
Dividend income and share of profits | 1 | 2 |
Derivatives | ||
Interest income and expenses | 157 | 283 |
Fair value gains and losses | -53 | -170 |
Total | 130 | 136 |
€ million | 2025 | 2024 |
Net income from assets at fair value through other comprehensive income | ||
Notes and bonds | ||
Capital gains and losses | 1 | 0 |
Other income and expenses | 0 | 0 |
Total | 1 | 0 |
€ million | 2025 | 2024 |
OP Pohjola's internal income | ||
Central banking service fees | 30 | 13 |
Other internal income received from OP Pohjola | 11 | 11 |
Other income from operations | 10 | 8 |
Other operating income | 0 | 0 |
Total other operating income | 51 | 33 |
€ million | 2025 | 2024 |
Wages and salaries | -63 | -60 |
Short-term employee benefits | ||
Personnel fund | -1 | -1 |
Performance-based bonuses | -13 | -15 |
Pension costs | ||
Defined contribution plans | -11 | -10 |
Defined benefit plans | 0 | 0 |
Other indirect personnel costs | -3 | -3 |
Total personnel costs | -91 | -90 |
€ million | 2025 | 2024 |
Depreciation and amortisation | ||
Machinery and equipment | 0 | 0 |
Information systems and other | 0 | -1 |
Right-of-use assets | -1 | -1 |
Other | 0 | 0 |
Impairment loss | ||
Other | 0 | 0 |
Total depreciation/amortisation and impairment loss | -1 | -1 |
€ million | 2025 | 2024 |
ICT expenses | ||
Production | -82 | -82 |
Development | -19 | -19 |
Charges of financial authorities | -6 | -5 |
Audit fees | -1 | -1 |
Service purchases | -37 | -29 |
Expert services | -2 | -2 |
Telecommunications | -2 | -2 |
Marketing | -2 | -2 |
Insurance and security costs | -14 | -17 |
Expenses from short-term and low-value leases | -1 | -1 |
Service charges to OP Cooperative | -30 | -26 |
Other | -18 | -20 |
Other operating expenses, total | -215 | -207 |
€ million | 2025 | 2024 |
ICT development expenses | -19 | -19 |
Share of own work | 0 | 0 |
Total development expenses in the income statement | -19 | -19 |
Capitalised ICT costs | -2 | -3 |
Total capitalised development costs | -2 | -3 |
Total development costs* | -22 | -22 |
Depreciation/amortisation and impairment loss on development costs | 0 | -1 |
€ million | 2025 | 2024 |
Current tax | -112 | -94 |
Tax for previous financial years | 0 | -6 |
Deferred tax | -9 | -1 |
Income tax expense on the income statement | -121 | -101 |
Corporate income tax rate | 20% | 20% |
€ million | 2025 | 2024 |
Earnings before tax | 559 | 473 |
Share of profit according to the tax rate | -112 | -95 |
Tax for previous financial years | 0 | -6 |
Tax-exempt income | 0 | 0 |
Non-deductible expenses | 0 | 0 |
Tax adjustments | -9 | 0 |
Other items | 0 | 0 |
Income tax expense on the income statement | -121 | -101 |
Recognised at fair value through profit or loss | |||||
Financial assets 31 December 2025, € million | Amortised cost | Recognised at fair value through other comprehensive income | Financial assets held for trading | Hedging derivatives | Carrying amount total |
Cash and deposits with central banks | 15,769 | 0 | 0 | 0 | 15,769 |
Receivables from credit institutions | 10,486 | 0 | 0 | 0 | 10,486 |
Receivables from customers | 29,181 | 0 | 0 | 0 | 29,181 |
Derivative contracts | 0 | 0 | 2,538 | 6 | 2,544 |
Notes and bonds | 2,339 | 14,895 | 390 | 0 | 17,625 |
Shares and participations | 0 | 0 | 3 | 0 | 3 |
Other financial assets | 617 | 0 | 0 | 0 | 617 |
Total | 58,392 | 14,895 | 2,931 | 6 | 76,224 |
Recognised at fair value through profit or loss | |||||
Financial assets 31 December 2024, € million | Amortised cost | Recognised at fair value through other comprehensive income | Financial assets held for trading | Hedging derivatives | Carrying amount total |
Cash and deposits with central banks | 18,071 | 0 | 0 | 0 | 18,071 |
Receivables from credit institutions | 10,753 | 0 | 0 | 0 | 10,753 |
Receivables from customers | 28,385 | 0 | 0 | 0 | 28,385 |
Derivative contracts | 0 | 0 | 3,279 | 104 | 3,383 |
Notes and bonds | 1,827 | 12,176 | 227 | 0 | 14,230 |
Shares and participations | 0 | 0 | 4 | 0 | 4 |
Other financial assets | 850 | 0 | 0 | 0 | 850 |
Total | 59,886 | 12,176 | 3,511 | 104 | 75,676 |
Financial liabilities 31 December 2025, € million | Recognised at fair value through profit or loss | Recognised at amortised cost | Hedging derivatives* | Carrying amount total |
Liabilities to credit institutions | 0 | 27,745 | 0 | 27,745 |
Liabilities to customers | 0 | 19,722 | 0 | 19,722 |
Derivative contracts | 2,528 | 0 | 119 | 2,647 |
Debt securities issued to the public | 1,804 | 15,395 | 0 | 17,199 |
Subordinated liabilities | 0 | 811 | 0 | 811 |
Other financial liabilities | 21 | 2,381 | 0 | 2,402 |
Total | 4,354 | 66,054 | 119 | 70,527 |
Financial liabilities 31 December 2024, € million | Recognised at fair value through profit or loss | Recognised at amortised cost | Hedging derivatives* | Carrying amount total | |||
Liabilities to credit institutions | 0 | 25,049 | 0 | 25,049 | |||
Liabilities to customers | 0 | 19,387 | 0 | 19,387 | |||
Derivative contracts | 3,061 | 0 | 89 | 3,150 | |||
Debt securities issued to the public | 2,201 | 17,126 | 0 | 19,326 | |||
Subordinated liabilities | 0 | 1,444 | 0 | 1,444 | |||
Other financial liabilities | 2 | 1,998 | 0 | 2,000 | |||
Total | 5,264 | 65,004 | 89 | 70,357 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Cash | 135 | 170 |
Deposits with central banks repayable on demand* | 15,634 | 17,901 |
Total cash and deposits with central banks | 15,769 | 18,071 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Deposits repayable on demand | 281 | 151 |
Other than repayable on demand deposits | 697 | 566 |
Loans and receivables repayable other than on demand | 9,509 | 10,037 |
Loss allowance* | -1 | -1 |
Total receivables from credit institutions | 10,486 | 10,753 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Loans to the public and public sector entities | 26,930 | 26,234 |
Finance lease receivables* | 2,473 | 2,408 |
Guarantee receivables | 0 | 0 |
Loss allowance** | -221 | -257 |
Total receivables from customers | 29,181 | 28,385 |
Total derivatives | 31 Dec 2025 | 31 Dec 2024 | ||||
€ million | Notional values | Fair values, assets | Fair values, liabilities | Notional values | Fair values, assets | Fair values, liabilities |
Interest rate derivatives | 248,241 | 2,113 | 2,145 | 272,388 | 2,648 | 2,486 |
Cleared by the central counterparty (STM) | 138,009 | 6 | 4 | 151,177 | 33 | 27 |
Equity and index-linked derivatives, of which | 1,001 | 101 | 25 | 1,172 | 76 | 64 |
Cleared by the central counterparty (STM) | 0 | 0 | 0 | |||
Currency and gold derivatives | 46,838 | 315 | 418 | 44,302 | 627 | 571 |
Cleared by the central counterparty (STM) | 0 | 0 | 0 | |||
Credit derivatives, of which | 190 | 10 | 1 | 280 | 10 | 2 |
Cleared by the central counterparty (STM) | 90 | 0 | 0 | 182 | 0 | 0 |
Commodity derivatives, of which | 654 | 5 | 60 | 410 | 22 | 26 |
Cleared by the central counterparty (STM) | 0 | 0 | 0 | |||
Other derivatives | 0 | 0 | 0 | 56 | ||
Cleared by the central counterparty (STM) | 0 | 0 | 0 | |||
Total derivatives | 296,924 | 2,544 | 2,647 | 318,607 | 3,383 | 3,150 |
Derivatives held for trading | 31 Dec 2025 | 31 Dec 2024 | ||||||
€ million | Notional values | Fair values, assets | Fair values, liabilities | of which sold options | Notional values | Fair values, assets | Fair values, liabilities | of which sold options |
Interest rate derivatives | 212,594 | 2,111 | 2,141 | 24,144 | 232,389 | 2,601 | 2,396 | 27,094 |
of which economic hedges | 864 | 10 | 2 | 234 | 2,603 | 12 | 56 | 621 |
OTC options | 48,926 | 782 | 777 | 24,144 | 54,460 | 984 | 912 | 27,094 |
OTC futures and interest rate swaps, of which | 163,574 | 1,330 | 1,365 | 177,780 | 1,618 | 1,484 | ||
Cleared by the central counterparty (STM) | 105,939 | 6 | 3 | 118,668 | 30 | 25 | ||
Standardised interest rate swaps | 94 | 0 | 0 | 150 | 0 | 0 | ||
Equity and index-linked derivatives | 1,001 | 101 | 25 | 1,172 | 76 | 64 | ||
of which economic hedges | 1,001 | 101 | 25 | 1,172 | 76 | 64 | ||
OTC swap contracts | 1,001 | 101 | 25 | 1,172 | 76 | 64 | ||
Currency and gold derivatives | 44,713 | 310 | 301 | 115 | 42,894 | 569 | 571 | |
of which economic hedges | 537 | 8 | 9 | 3 | 0 | 0 | ||
OTC options | 232 | 1 | 1 | 115 | 399 | 1 | 1 | |
OTC forwards and interest rate and currency swaps | 44,481 | 309 | 301 | 42,495 | 568 | 570 | ||
Credit derivatives | 190 | 10 | 1 | 10 | 280 | 10 | 2 | 76 |
of which economic hedges | 100 | 10 | 1 | 98 | 10 | 2 | ||
OTC credit derivatives, of which | 190 | 10 | 1 | 10 | 280 | 10 | 2 | 76 |
Cleared by the central counterparty (STM) | 90 | 0 | 0 | 10 | 182 | 0 | 0 | 76 |
Commodity derivatives | 654 | 5 | 60 | 410 | 22 | 26 | ||
of which economic hedges | 199 | 0 | 8 | 32 | 0 | 1 | ||
OTC forwards and swap contracts | 558 | 5 | 60 | 374 | 22 | 26 | ||
Standardised futures | 96 | 0 | 0 | 35 | 1 | 0 | ||
Other derivatives | 56 | |||||||
Other standardised | 56 | |||||||
Total derivatives held for trading | 259,152 | 2,538 | 2,528 | 24,269 | 277,201 | 3,279 | 3,059 | 27,170 |
Derivative contracts used for hedge accounting – fair value hedging | 31 Dec 2025 | 31 Dec 2024 | ||||||
Notional values by residual term to maturity | Notional values by residual term to maturity | |||||||
€ million | < 1 year | 1–5 years | < 5 years | Total | < 1 yr | 1–5 years | < 5 years | Total |
Interest rate derivatives, of which | 4,303 | 24,354 | 6,739 | 35,396 | 7,364 | 26,155 | 6,479 | 39,999 |
Cleared by the central counterparty (STM) | 2,666 | 22,576 | 6,578 | 31,820 | 5,127 | 21,139 | 6,242 | 32,509 |
Currency and gold derivatives | 1,004 | 516 | 278 | 1,798 | ||||
Cleared by the central counterparty (STM) | ||||||||
Total derivatives | 5,307 | 24,870 | 7,018 | 37,195 | 7,364 | 26,155 | 6,479 | 39,999 |
Derivative contracts used for hedge accounting – cash flow hedging | 31 Dec 2025 | 31 Dec 2024 | ||||||
Notional values by residual term to maturity | Notional values by residual term to maturity | |||||||
€ million | < 1 year | 1–5 years | < 5 years | Total | < 1 yr | 1–5 years | < 5 years | Total |
Interest rate derivatives, of which | 100 | 150 | 250 | |||||
Cleared by the central counterparty (STM) | 100 | 150 | 250 | |||||
Currency and gold derivatives | 327 | 327 | 1,407 | 1,407 | ||||
Cleared by the central counterparty (STM) | 0 | |||||||
Total derivatives | 327 | 100 | 150 | 577 | 1,407 | 1,407 | ||
31 Dec 2025 | 31 Dec 2024 | |||||||
Average interest rates of interest rate swaps in hedge accounting – fair value hedge | < 1 year | 1–5 years | < 5 years | Total | < 1 yr | 1–5 years | < 5 years | Total |
Interest rate derivatives | ||||||||
Cleared by the central counterparty | 0.488 | 0.908 | 1.624 | 1.127 | 0.855 | 2.127 | 1.106 | 0.867 |
OTC interest rate derivatives | 3.090 | 2.890 | 2.964 | -0.345 | -0.318 | 3.009 | -0.243 | |
Total interest rate derivatives | 0.488 | 0.914 | 1.634 | 1.135 | 0.296 | 0.623 | 1.119 | 0.312 |
31 Dec 2025 | 31 Dec 2024 | |||||||
Average interest rates of interest rate swaps and currency swaps in hedge accounting related to significant currencies | < 1 year | 1–5 years | < 5 years | Total | < 1 yr | 1–5 years | < 5 years | Total |
AUD | 2.440 | 2.440 | 2.440 | 2.440 | ||||
GBP | 1.380 | 1.380 | 2.318 | 2.318 | ||||
HKD | 2.880 | 2.880 | 3.000 | 2.880 | 2.958 | |||
JPY | 1.746 | 1.746 | 0.700 | 1.300 | 0.831 | |||
SEK | 4.450 | 4.450 | 4.450 | 4.450 | ||||
NOK | 4.089 | 4.786 | 4.427 | 4.334 | 4.334 | |||
USD | 3.607 | 3.607 | 3.823 | 2.930 | 3.607 | |||
31 Dec 2025 | 31 Dec 2024 | |||||||
Average interest rates of interest rate swaps in hedge accounting – cash flow hedge | < 1 year | 1–5 years | < 5 years | Total | < 1 yr | 1–5 years | < 5 years | Total |
Interest rate derivatives | ||||||||
Cleared by the central counterparty | 2.222 | 2.222 | ||||||
Total interest rate derivatives | 2.222 | 2.222 | ||||||
31 Dec 2025 | 31 Dec 2024 | |||||||
Average prices of currency derivatives in hedge accounting related to significant currencies | < 1 yr | 1–5 years | < 5 years | Total | < 1 yr | 1–5 years | < 5 years | Total |
Currency derivatives | ||||||||
Forward exchange contracts | ||||||||
Average EUR:AUD | 1.741 | 1.741 | ||||||
Average EUR:CHF | 0.953 | 0.953 | ||||||
Average EUR:GBP | 0.870 | 0.870 | 0.861 | 0.861 | ||||
Average EUR:USD | 1.171 | 1.171 | 1.020 | 1.020 | ||||
Hedged item | Balance sheet item in which the hedged item is presented | Carrying amount of hedged item including accrued amount of hedge adjustments | Accrued amount of hedge adjustments for the hedged item | Change in value of hedged item that is used as basis for recognition of ineffective hedge during period | Ineffectiveness recognised in the income statement | ||
31 Dec 2025, € million | Assets | Liabilities | Assets | Liabilities | |||
Fair value micro hedging, interest rate risk | |||||||
Bonds (FVOCI) | Investment assets | 13,987 | -437 | -8 | 0 | ||
Receivables from customers | Receivables from customers | 375 | -7 | 10 | 0 | ||
Debt issues | Debt securities issued to the public | 8,557 | -272 | -116 | -3 | ||
Debt issues | Subordinated liabilities | 557 | -3 | -7 | -1 | ||
Fair value portfolio hedging, interest rate risk | |||||||
Receivables from customers | Receivables from customers | 3,223 | -4 | -2 | 0 | ||
Liabilities to credit institutions | 0 | 8,601 | 0 | -228 | -72 | 0 | |
Hedged item | Balance sheet item in which the hedged item is presented | Carrying amount of hedged item including accrued amount of hedge adjustments | Accrued amount of hedge adjustments for the hedged item | Change in value of hedged item that is used as basis for recognition of ineffective hedge during period | Ineffectiveness recognised in the income statement | ||
31 Dec 2024, € million | Assets | Liabilities | Assets | Liabilities | |||
Fair value micro hedging, interest rate risk | |||||||
Bonds (FVOCI) | Investment assets | 11,333 | -453 | 247 | -3 | ||
Receivables from customers | Receivables from customers | 365 | -17 | 19 | 5 | ||
Debt issues | Debt securities issued to the public | 11,296 | -384 | -222 | 2 | ||
Debt issues | Subordinated liabilities | 1,089 | -11 | -30 | 0 | ||
Fair value portfolio hedging, interest rate risk | |||||||
Liabilities to credit institutions | Liabilities to credit institutions | 7,438 | 0 | -301 | -167 | 0 | |
Receivables from customers | Receivables from customers | 5,218 | 0 | 2 | -1 | ||
Hedged item | Balance sheet item in which the hedged item is presented | Change in value of hedged item that is used as basis for recognition of ineffective hedge during period | Cash flow hedge reserve balance | Ineffectiveness recognised in the income statement | |
31 Dec 2025, € million | Terminated hedging | ||||
Cash flow portfolio hedging, interest rate risk | |||||
Deposits | Cash and deposits with central banks | 1 | -1 | 0 | |
Current liabilities | Liabilities to customers | 0 | 0 | 0 | |
Short-term debt issues | Debt securities issued to the public | 0 | 0 | 0 | |
Hedged item | Balance sheet item in which the hedged item is presented | Change in value of hedged item that is used as basis for recognition of ineffective hedge during period | Cash flow hedge reserve balance | Ineffectiveness recognised in the income statement | |
31 Dec 2024, € million | Continuous hedging | Terminated hedging | |||
Cash flow portfolio hedging, interest rate risk | |||||
Deposits | Cash and deposits with central banks | 0 | 0 | 0 | |
Current liabilities | Liabilities to customers | 0 | 0 | 0 | |
Short-term debt issues | Debt securities issued to the public | 1 | 0 | 0 | |
Hedging instruments | Notional values | Value of hedging derivatives | Change in the fair value of hedging derivatives used as basis for ineffectiveness calculation | |
31 Dec 2025, € million | Positive | Negative | ||
Fair value micro hedging, interest rate risk | ||||
Cross currency swaps | 24,378 | 509 | -341 | 118 |
Fair value portfolio hedging, interest rate risk | ||||
Interest rate swaps | 7,658 | 19 | -240 | 73 |
Interest rate options | 3,128 | 0 | 1 | |
Cash flow portfolio hedging, interest rate risk | ||||
Interest rate swaps | 250 | 0 | -1 | -1 |
Currency risk hedge | ||||
Forward exchange contracts | 325 | 0 | 0 | 1 |
Hedging instruments | Notional values | Value of hedging derivatives | Change in the fair value of hedging derivatives used as basis for ineffectiveness calculation | |
31 Dec 2024, € million | Positive | Negative | ||
Fair value micro hedging, interest rate risk | ||||
Cross currency swaps | 24,739 | 590 | -517 | -5 |
Fair value portfolio hedging, interest rate risk | ||||
Interest rate swaps | 7,438 | 26 | -320 | 157 |
Interest rate options | 5,087 | -1 | 2 | |
Cash flow portfolio hedging, interest rate risk | ||||
Interest rate swaps | 0 | 0 | 0 | 9 |
Currency risk hedge | ||||
Forward exchange contracts | 1,407 | 0 | -1 | -1 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Financial assets at fair value through other comprehensive income | ||
Notes and bonds | 14,895 | 12,176 |
Shares and participations | 0 | 0 |
Total | 14,895 | 12,176 |
Financial assets held for trading | ||
Notes and bonds | 390 | 227 |
Shares and participations | 3 | 4 |
Total | 393 | 232 |
Amortised cost | ||
Notes and bonds | 2,339 | 1,827 |
Total | 2,339 | 1,827 |
Total investment assets | 17,627 | 14,234 |
Changes in intangible assets, € million | Information systems |
Acquisition cost 1 January 2025 | 40 |
Increases | 2 |
Acquisition cost 31 December 2025 | 42 |
Accumulated depreciation and impairments 1 January 2025 | -37 |
Depreciation for the financial year | 0 |
Accumulated depreciation and impairments 31 December 2025 | -38 |
Carrying amount 31 December 2025 | 5 |
Changes in intangible assets, € million | Information systems |
Acquisition cost 1 January 2024 | 39 |
Increases | 3 |
Decreases | -1 |
Transfers between items | 0 |
Acquisition cost 31 December 2024 | 40 |
Accumulated depreciation and impairments 1 January 2024 | -38 |
Depreciation for the financial year | -1 |
Decreases | 1 |
Transfers between items | 0 |
Accumulated amortisation and impairments 31 December 2024 | -37 |
Carrying amount 31 December 2024 | 3 |
Buildings | 20–50 years |
Machinery and equipment | 3–10 years |
Cars | 2–6 years |
Other PPE assets | 3–10 years |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Property in own use | ||
Land and water areas | 0 | 0 |
Machinery and equipment | 0 | 0 |
Other PPE assets | 3 | 2 |
Right-of-use assets | 2 | 1 |
Total property, plant and equipment | 5 | 4 |
Changes in property, plant and equipment (PPE), € million | Property in own use | Machinery and equipment | Other PPE assets | Total property, plant and equipment |
Acquisition cost 1 January 2025 | 1 | 0 | 2 | 3 |
Increases | 0 | 11 | 11 | |
Decreases | 0 | -10 | -10 | |
Acquisition cost 31 December 2025 | 1 | 0 | 3 | 4 |
Accumulated depreciation and impairments 1 January 2025 | 0 | 0 | 0 | -1 |
Depreciation for the financial year | 0 | 0 | 0 | |
Decreases | 0 | 0 | ||
Accumulated depreciation and impairments 31 December 2025 | 0 | 0 | 0 | -1 |
Right-of-use asset* | 2 | |||
Carrying amount 31 December 2025 | 0 | 0 | 3 | 5 |
Changes in property, plant and equipment (PPE), € million | Property in own use | Machinery and equipment | Other PPE assets | Total property, plant and equipment |
Acquisition cost 1 January 2024 | 1 | 0 | 2 | 3 |
Increases | 0 | 7 | 7 | |
Decreases | 0 | -7 | -7 | |
Transfers between items | 0 | 0 | ||
Acquisition cost 31 December 2024 | 1 | 0 | 2 | 3 |
Accumulated depreciation and impairments 1 January 2024 | 0 | 0 | 0 | -1 |
Depreciation for the financial year | 0 | 0 | 0 | |
Decreases | 0 | 0 | ||
Transfers between items | 0 | 0 | ||
Accumulated depreciation and impairments 31 December 2024 | 0 | 0 | 0 | -1 |
Right-of-use asset* | 1 | |||
Carrying amount 31 December 2024 | 0 | 0 | 2 | 4 |
2025 | 2024 | |||||
Right-of-use assets, € million | Buildings | Machinery and equipment | Total | Buildings | Machinery and equipment | Total |
Carrying amount 1 January | 1 | 0 | 1 | 2 | 0 | 2 |
Increases | 1 | 1 | 1 | 0 | 0 | |
Decreases | 0 | 0 | 0 | 0 | 0 | |
Depreciation for the financial year | 0 | 0 | -1 | 0 | 0 | -1 |
Value changes for the financial year | 0 | 0 | 0 | 0 | 0 | 0 |
Carrying amount 31 December | 1 | 1 | 2 | 1 | 0 | 1 |
Lease liabilities, € million | 31 Dec 2025 | 31 Dec 2024 |
* Carrying amount | 2 | 1 |
Contractual maturities | ||
< 1 year | 1 | 1 |
1–2 years | 1 | 0 |
2–3 years | 0 | 0 |
3–4 years | 0 | 0 |
4–5 years | 0 | 0 |
Over 5 years | 0 | 0 |
Items entered in the income statement, € million | 31 Dec 2025 | 31 Dec 2024 |
Interest expenses | 0 | 0 |
Depreciation on right-of-use assets | -1 | -1 |
Expenses from short-term and low-value leases | -1 | -1 |
Total cash flow from leases | -2 | -2 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Maturity of finance lease receivables | ||
< 1 year | 830 | 756 |
1–2 years | 641 | 665 |
2–3 years | 482 | 448 |
3–4 years | 309 | 306 |
4–5 years | 157 | 174 |
Over 5 years | 167 | 200 |
Gross investment in finance leases | 2,587 | 2,550 |
Unearned finance income (–) | -115 | -142 |
Present value of minimum lease payments | 2,473 | 2,408 |
Present value of minimum lease payment receivables | ||
< 1 year | 789 | 708 |
1–2 years | 615 | 633 |
2–3 years | 466 | 429 |
3–4 years | 299 | 294 |
4–5 years | 151 | 167 |
Over 5 years | 153 | 177 |
Total | 2,473 | 2,408 |
Items entered in the income statement, € million | 31 Dec 2025 | 31 Dec 2024 |
Interest income from finance lease receivables | 96 | 112 |
Adjusted | ||
€ million | 31 Dec 2025 | 31 Dec 2024 |
Payment transfer receivables | 124 | 153 |
Pension assets | 26 | 23 |
Accrued income and prepaid expenses | 13 | 26 |
Derivatives receivables, central counterparty clearing | 46 | 69 |
CSA receivables, central counterparty clearing | 173 | 371 |
Securities receivables | 19 | 7 |
Other | 243 | 201 |
Total | 643 | 850 |
Deferred tax assets, € million | 1 Jan 2025 | Recognised in the income statement | Recognised in other comprehensive income | Recognised in equity | 31 Dec 2025 |
Notes and bonds | 24 | 0 | -18 | 0 | 6 |
Cash flow hedges | 0 | 0 | 0 | 0 | 0 |
Defined benefit pension plans | 12 | -11 | 0 | 0 | 1 |
Leases | 0 | 0 | 0 | 0 | 0 |
Other temporary differences | 2 | 1 | 2 | 0 | 5 |
Set-off against deferred tax liabilities | -39 | -12 | |||
Total | 0 | -11 | -16 | 0 | 0 |
Deferred tax liabilities, € million | 1 Jan 2025 | Recognised in the income statement | Recognised in other comprehensive income | Recognised in equity | 31 Jan 2025 |
Tax provisions | 325 | 0 | 0 | 0 | 325 |
Notes and bonds | 1 | 0 | 0 | 0 | 0 |
Defined benefit pension plans | 7 | -2 | 0 | 0 | 5 |
Other temporary differences | 1 | 0 | 0 | 0 | 1 |
Set-off against deferred tax assets | -39 | -12 | |||
Total | 295 | -2 | 0 | 0 | 319 |
Change in deferred tax in the income statement (deferred tax assets – deferred tax liabilities) | -9 | -16 |
Deferred tax assets, € million | 1 Jan 2024 | Recognised in the income statement | Recognised in other comprehensive income | Recognised in equity | 31 Dec 2024 |
Notes and bonds | 15 | 0 | 9 | 0 | 24 |
Provisions | 0 | 0 | 0 | 0 | 0 |
Cash flow hedges | 2 | 0 | -2 | 0 | 0 |
Defined benefit pension plans | 12 | 0 | 0 | 0 | 12 |
Leases | 0 | 0 | 0 | 0 | 0 |
Other temporary differences | 3 | 0 | 0 | 0 | 2 |
Set-off against deferred tax liabilities | -39 | ||||
Total | 31 | -1 | 8 | 0 | 0 |
Deferred tax liabilities, € million | 1 Jan 2024 | Recognised in the income statement | Recognised in other comprehensive income | Recognised in equity | 31 Dec 2024 |
Tax provisions | 325 | 0 | 0 | 0 | 325 |
Notes and bonds | 0 | 0 | 0 | 0 | 1 |
Defined benefit pension plans | 6 | 0 | 1 | 0 | 7 |
Other temporary differences | 1 | 0 | 0 | 0 | 1 |
Set-off against deferred tax assets | -39 | ||||
Total | 332 | 0 | 1 | 0 | 295 |
Change in deferred tax in the income statement (deferred tax assets – deferred tax liabilities) | -1 | 7 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Liabilities to credit institutions | ||
Repayable on demand | ||
Deposits | 6,506 | 4,556 |
Other liabilities | 0 | 0 |
Other than repayable on demand | ||
Deposits | 21,468 | 20,794 |
Other liabilities | -229 | -301 |
Total liabilities to credit institutions and central banks | 27,745 | 25,049 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Deposits repayable on demand | ||
Private | 13 | 14 |
Companies and public-sector entities | 15,811 | 14,892 |
Other than repayable on demand deposits | ||
Private | 1 | 0 |
Companies and public-sector entities | 1,162 | 2,254 |
Interest payable on deposits | 14 | 5 |
Financial liabilities repayable on demand | ||
Companies and public-sector entities | 4 | 6 |
Other than repayable on demand financial liabilities | ||
Companies and public-sector entities | 2,718 | 2,215 |
Total liabilities to customers | 19,722 | 19,387 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Senior Preferred bonds* | 9,000 | 11,139 |
Senior Non-preferred bonds | 3,621 | 3,566 |
Certificates of deposit | 0 | 170 |
Commercial papers | 4,579 | 4,451 |
Total debt securities issued to the public | 17,199 | 19,326 |
Reconciliation of changes in liabilities in cash flows from financing activities against balance sheet items | Debt securities issued to the public | Subordinated liabilities | Debt securities issued to the public | Subordinated liabilities |
€ million | 2025 | 2024 | ||
Balance sheet value 1 January | 19,326 | 1,444 | 24,062 | 1,414 |
Changes in cash flows from financing activities | ||||
Increases in bonds | 2,550 | 1,710 | ||
Increases in certificates of deposit | 323 | 401 | ||
Increases in commercial papers | 5,861 | 5,753 | ||
Increases in debentures | 807 | 1 | ||
Increases total | 8,733 | 807 | 7,865 | 1 |
Decreases in bonds | -4,841 | -4,627 | ||
Decreases in certificates of deposit | -493 | -913 | ||
Decreases in commercial papers | -5,733 | -7,503 | ||
Decreases in debentures | -1,456 | 0 | ||
Decreases total | -11,066 | -1,456 | -13,043 | 0 |
Total changes in cash flows from financing activities | -2,333 | -649 | -5,179 | 1 |
Valuations | 204 | 9 | 467 | 19 |
Interest carried forward | 2 | 7 | -25 | 11 |
Balance sheet value 31 December | 17,199 | 811 | 19,326 | 1,444 |
Maturity | Priority class | Currency | Interest rate | Nominal value | Fair value |
14.01.2026 | Senior Preferred | EUR | Fixed 0.910% | 20 | 20 |
14.01.2026 | Senior Preferred | GBP | Fixed 3.375% | 401 | 414 |
21.01.2026 | Senior Preferred | HKD | Fixed 2.880% | 72 | 74 |
16.02.2026 | Senior Preferred | SEK | SES3 + 1.050% | 46 | 46 |
24.03.2026 | Senior Non- Preferred | EUR | Fixed 0.250% | 500 | 499 |
01.07.2026 | Senior Preferred | EUR | Fixed 0.250% | 50 | 49 |
04.09.2026 | Senior Non- Preferred | GBP | Fixed 1.375% | 458 | 452 |
23.10.2026 | Senior Preferred | SEK | Fixed 4.454% | 65 | 66 |
18.01.2027 | Senior Non- Preferred | EUR | Fixed 0.600% | 500 | 493 |
28.03.2027 | Senior Preferred | EUR | EUB3 + 0.400% | 500 | 501 |
18.04.2027 | Senior Preferred | EUR | Fixed 4.125% | 500 | 525 |
18.05.2027 | Senior Preferred | EUR | Fixed 1.058% | 10 | 10 |
19.05.2027 | Senior Preferred | EUR | EUB3 + 0.400% | 1,250 | 1,255 |
20.05.2027 | Senior Preferred | EUR | Fixed 2.335% | 30 | 30 |
25.05.2027 | Senior Preferred | EUR | Fixed 1.873% | 35 | 35 |
27.07.2027 | Senior Non- Preferred | EUR | Fixed 0.625% | 500 | 487 |
19.08.2027 | Senior Preferred | SEK | SES3 + 0.920% | 69 | 70 |
Maturity | Priority class | Currency | Interest rate | Nominal value | Fair value |
23.08.2027 | Senior Preferred | EUR | Fixed 3.286% | 50 | 51 |
08.10.2027 | Senior Preferred | EUR | Fixed 1.000% | 25 | 25 |
16.11.2027 | Senior Preferred | EUR | Fixed 0.100% | 1,000 | 957 |
13.06.2028 | Senior Preferred | EUR | Fixed 4.000% | 650 | 684 |
13.06.2028 | Senior Preferred | SEK | SES3 + 0.470% | 46 | 46 |
15.06.2028 | Senior Preferred | USD | Fixed 3.692% | 51 | 51 |
16.06.2028 | Senior Non- Preferred | EUR | Fixed 0.375% | 500 | 474 |
23.10.2028 | Senior Preferred | EUR | Fixed 1.300% | 10 | 9 |
07.12.2028 | Senior Preferred | USD | Fixed 3.901% | 85 | 85 |
08.12.2028 | Senior Non- Preferred | EUR | Fixed 0.375% | 500 | 465 |
24.01.2029 | Senior Preferred | EUR | Fixed 1.310% | 10 | 10 |
20.02.2029 | Senior Preferred | EUR | EUB3 + 0.860% | 75 | 75 |
06.03.2029 | Senior Preferred | EUR | Fixed 1.005% | 19 | 18 |
25.05.2029 | Senior Preferred | NOK | Fixed 3.755% | 76 | 77 |
25.05.2029 | Senior Preferred | AUD | BBSW3 + 1.300% | 37 | 38 |
27.05.2029 | Senior Preferred | NOK | Fixed 3.800% | 17 | 17 |
10.07.2029 | Senior Preferred | AUD | Fixed 2.440% | 112 | 105 |
17.07.2029 | Senior Non- Preferred | USD | Fixed 2.933% | 43 | 41 |
Maturity | Priority class | Currency | Interest rate | Nominal value | Fair value |
12.11.2029 | Senior Non- Preferred | EUR | Fixed 0.625% | 500 | 456 |
15.11.2029 | Senior Preferred | EUR | Fixed 0.530% | 10 | 9 |
27.11.2029 | Senior Preferred | EUR | Fixed 2.875% | 500 | 502 |
07.12.2029 | Senior Preferred | NOK | Fixed 4.400% | 101 | 101 |
23.05.2030 | Senior Preferred | EUR | EUB3 + 0.920% | 25 | 25 |
30.05.2030 | Senior Preferred | EUR | Fixed 2.900% | 25 | 25 |
10.06.2030 | Senior Preferred | SEK | SES3 + 0.750% | 92 | 93 |
18.06.2030 | Senior Preferred | EUR | Fixed 2.875% | 500 | 504 |
21.08.2030 | Senior Preferred | EUR | Fixed 1.700% | 30 | 30 |
02.09.2030 | Senior Preferred | JPY | Fixed 1.385% | 27 | 27 |
18.09.2030 | Senior Preferred | EUR | EUB6 + 0.500% | 25 | 26 |
18.11.2030 | Senior Preferred | EUR | Fixed 2.045% | 50 | 47 |
27.01.2031 | Senior Preferred | EUR | Fixed 1.865% | 10 | 9 |
24.03.2031 | Senior Non- Preferred | EUR | Fixed 0.750% | 300 | 266 |
11.11.2032 | Senior Preferred | NOK | Fixed 5.010% | 72 | 73 |
23.11.2032 | Senior Preferred | EUR | Fixed 4.148% | 50 | 51 |
12.12.2033 | Senior Preferred | EUR | Fixed 1.706% | 50 | 43 |
21.03.2034 | Senior Preferred | EUR | Fixed 3.068% | 30 | 29 |
Maturity | Priority class | Currency | Interest rate | Nominal value | Fair value |
31.03.2034 | Senior Preferred | EUR | Fixed 3.015% | 30 | 29 |
11.04.2034 | Senior Preferred | EUR | Fixed 3.000% | 40 | 38 |
16.03.2035 | Senior Preferred | EUR | Fixed 1.400% | 40 | 32 |
28.08.2035 | Senior Preferred | NOK | Fixed 4.600% | 72 | 71 |
03.10.2035 | Senior Preferred | NOK | Fixed 4.700% | 59 | 59 |
09.10.2035 | Senior Preferred | EUR | EUB6 + 0.700% | 40 | 39 |
20.11.2035 | Senior Preferred | EUR | Fixed 2.155% | 30 | 25 |
27.11.2035 | Senior Preferred | JPY | Fixed 1.300% | 14 | 12 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Provisions | ||
Loss allowance on off-balance sheet items | 30 | 38 |
Other liabilities | ||
Payment transfer liabilities | 1,572 | 928 |
Accrued expenses and deferred income | 55 | 53 |
Derivative CSA and other liabilities | 762 | 1,015 |
Pension liabilities | 3 | 4 |
Lease liabilities | 2 | 1 |
Accounts payable on securities | 12 | 8 |
Reverse factoring arrangements | 4 | 6 |
Financial liabilities held for trading | 21 | 2 |
Other | 87 | 85 |
Total provisions and other liabilities | 2,548 | 2,142 |
€ million | Loss allowance | Reorganisation | Total |
1 Jan 2025 | 38 | 38 | |
Provisions used | -9 | -9 | |
31 Dec 2025 | 30 | 0 | 30 |
€ million | Loss allowance | Reorganisation | Total |
1 Jan 2024 | 37 | 0 | 37 |
Increase in provisions | 1 | 1 | |
Reversal of unused provisions | 0 | 0 | |
31 Dec 2024 | 38 | 0 | 38 |
Defined benefit pension obligations | Fair value of pension plan assets | Net liabilities (assets) | ||||
Balance sheet value of defined benefit pension plans, € million | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2025 | 31 Dec 2024 |
Opening balance 1 Jan | 37 | 43 | -56 | -58 | -19 | -14 |
Defined benefit pension costs recognised in income statement | ||||||
Current service cost | 0 | 0 | 0 | 0 | ||
Interest expense (income) | 1 | 1 | -2 | -2 | -1 | 0 |
Administrative expenses | 0 | 0 | 0 | 0 | ||
Total | 1 | 1 | -2 | -2 | 0 | 0 |
Losses (gains) recognised in other comprehensive income arising from remeasurement | ||||||
Actuarial losses (gains) arising from changes in economic expectations | -2 | -2 | -2 | -2 | ||
Experience adjustments | -2 | -3 | -2 | -3 | ||
Return on plan assets, excluding amount (–) of net defined benefit liability (asset) | 2 | 1 | 2 | 1 | ||
Total | -5 | -5 | 2 | 1 | -3 | -4 |
Other | ||||||
Employer contributions | 0 | 0 | 0 | 0 | ||
Benefits paid | -3 | -3 | 3 | 3 | ||
Total | -3 | -3 | 2 | 2 | 0 | 0 |
Closing balance 31 Dec | 31 | 37 | -53 | -56 | -22 | -19 |
Liabilities and assets recognised in the balance sheet, € million | 31 Dec 2025 | 31 Dec 2024 |
Net assets (–) (Pension foundation) | -25 | -22 |
Net liabilities (Supplementary pension plans of insurance companies) | 3 | 4 |
Net assets (–) (Supplementary pension plans of insurance companies) | 0 | 0 |
Total net liabilities | 3 | 4 |
Total net assets | -26 | -23 |
Pension foundation assets, € million | 31 Dec 2025 | 31 Dec 2024 |
Shares and participations | 10 | 10 |
Bonds | 0 | 8 |
Real property | 0 | 0 |
Mutual funds | 38 | 32 |
Derivatives | 0 | 0 |
Other assets | 1 | 2 |
Total | 50 | 52 |
Pension plan assets include, € million, | 31 Dec 2025 | 31 Dec 2024 |
Other receivables from OP Pohjola companies | 1 | 2 |
Total | 1 | 2 |
31 Dec 2025 | 31 Dec 2024 | |||
Principal actuarial assumptions used | Pension foundation | Insurance companies | Pension foundation | Insurance companies |
Discount rate, % | 3.9 | 4.2 | 3.2 | 3.4 |
Future pay increase assumption, % | 2.8 | 2.8 | 2.7 | 2.8 |
Future pension increases, % | 2.1 | 2.2 | 2.1 | 2.1 |
Turnover rate, % | 0.0 | 0.0 | 0.0 | 0.0 |
Inflation rate, % | 2.0 | 2.0 | 1.9 | 2.0 |
Estimated remaining service life of employees in years | 4.0 | 4.0 | 4.0 | 5.0 |
Life expectancy for 65-year old people | ||||
Men | 22.9 | 22.9 | 21.4 | 21.4 |
Women | 27.2 | 27.2 | 25.4 | 25.4 |
Life expectancy for 45-year old people after 20 years | ||||
Men | 25.4 | 25.4 | 23.7 | 23.7 |
Women | 29.8 | 29.8 | 28.1 | 28.1 |
Pension foundation, change in defined benefit net pension liability | Supplementary pension plans of insurance companies, change in defined benefit net pension liability | |||
Sensitivity analysis of key actuarial assumptions, 31 Dec 2025 | € million | % | € million | % |
Discount rate | ||||
0.5 pp increase | -1 | -4.6 | 0 | -7.0 |
0.5 pp decrease | 1 | 5.1 | 0 | 7.8 |
Pension increases | ||||
0.5 pp increase | 1 | 4.9 | 0 | 62.6 |
0.5 pp decrease | -1 | -4.7 | 0 | -59.3 |
Mortality | ||||
1-year increase in life expectancy | 1 | 3.5 | 0 | 3.2 |
1-year decrease in life expectancy | -1 | -3.3 | 0 | -3.1 |
Pension foundation, change in defined benefit net pension liability | ||||
Sensitivity analysis of key actuarial assumptions, 31 Dec 2024 | € million | % | € million | % |
Discount rate | ||||
0.5 pp increase | -1 | -5.0 | 0 | -7.2 |
0.5 pp decrease | 2 | 5.5 | 0 | 8.1 |
Pension increases | ||||
0.5 pp increase | 2 | 5.3 | 0 | 56.2 |
0.5 pp decrease | -1 | -5.0 | 0 | -53.0 |
Mortality | ||||
1-year increase in life expectancy | 1 | 3.4 | 0 | 3.4 |
1-year decrease in life expectancy | -1 | -3.3 | 0 | -3.2 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Debentures | 811 | 1,444 |
Total subordinated liabilities | 811 | 1,444 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Share capital | 428 | 428 |
Reserves | ||
Restricted reserves | ||
Share premium account | 524 | 524 |
Legal reserve | 164 | 164 |
Fair value reserve | ||
On cash flow hedging | -1 | 0 |
On fair value measurement | -24 | -88 |
Non-restricted reserves | ||
Reserve for invested unrestricted equity | 308 | 308 |
Other non-restricted reserves | 23 | 23 |
Retained earnings | ||
Profit (loss) for previous periods | 3,396 | 3,135 |
Profit (loss) for the financial year | 437 | 372 |
Total equity capital | 5,255 | 4,866 |
€ million | Notes and bonds | Cash flow hedges | Total |
Opening balance 1 January 2024 | -57 | -6 | -63 |
Fair value changes | -37 | -2 | -40 |
Capital gains/losses transferred to income statement | -1 | -1 | |
Transfers to net interest income | 10 | 10 | |
Deferred tax | 8 | -2 | 6 |
Closing balance 31 December 2024 | -88 | 0 | -88 |
€ million | Notes and bonds | Cash flow hedges | Total |
Opening balance 1 January 2025 | -88 | 0 | -88 |
Fair value changes | 77 | -1 | 76 |
Capital gains/losses transferred to income statement | 2 | 2 | |
Transfers to net interest income | 0 | 0 | |
Deferred tax | -16 | 0 | -16 |
Closing balance 31 December 2025 | -24 | -1 | -25 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Equity capital | ||
Restricted equity | 1,091 | 1,028 |
Non-restricted equity | 4,164 | 3,838 |
Total equity capital | 5,255 | 4,866 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Distributable funds | ||
Reserve for invested unrestricted equity | 308 | 308 |
Other non-restricted reserves | 23 | 23 |
Fair value reserve | -25 | -88 |
Retained earnings, defined benefit plans | -58 | -60 |
Retained earnings for previous financial years | 2,160 | 1,900 |
Tax-based provisions transferred in transition to IFRS | 1,300 | 1,300 |
Profit for the financial year | 437 | 372 |
Capitalised development expenditure | -5 | -3 |
Total distributable funds | 4,141 | 3,753 |
Exposures | Stage 1 | Stage 2 | Stage 3* | |||
31 December 2025, € million | Not more than 30 DPD | More than 30 DPD | Total | Total exposures | ||
Receivables from customers (gross) | ||||||
Corporate Banking | 26,187 | 2,759 | 215 | 2,974 | 456 | 29,618 |
Total receivables from customers | 26,187 | 2,759 | 215 | 2,974 | 456 | 29,618 |
Off-balance-sheet limits | ||||||
Corporate Banking | 3,710 | 99 | 13 | 111 | 4 | 3,824 |
Total limits | 3,710 | 99 | 13 | 111 | 4 | 3,824 |
Other off-balance-sheet commitments | ||||||
Corporate Banking | 2,760 | 126 | 26 | 152 | 24 | 2,936 |
Total other off-balance-sheet commitments | 2,760 | 126 | 26 | 152 | 24 | 2,936 |
Notes and bonds | ||||||
Group Functions | 16,817 | 95 | 95 | 16,912 | ||
Total notes and bonds | 16,817 | 95 | 0 | 95 | 0 | 16,912 |
Total exposures within the scope of accounting for expected credit losses | 49,473 | 3,079 | 253 | 3,333 | 484 | 53,290 |
On-balance-sheet exposures and related off-balance-sheet limits* | Stage 1 | Stage 2 | Stage 3**** | |||
31 December 2025, € million | Not more than 30 DPD | More than 30 DPD | Total | Total loss allowance | ||
Receivables from customers | ||||||
Corporate Banking | -40 | -61 | -5 | -66 | -115 | -222 |
Total receivables from customers | -40 | -61 | -5 | -66 | -115 | -222 |
Off-balance-sheet commitments** | ||||||
Corporate Banking | -3 | -8 | -3 | -11 | -15 | -30 |
Total off-balance-sheet commitments | -3 | -8 | -3 | -11 | -15 | -30 |
Notes and bonds*** | ||||||
Group Functions | -1 | -1 | -1 | -2 | ||
Total notes and bonds | -1 | -1 | 0 | -1 | -2 | |
Total | -45 | -71 | -8 | -79 | -130 | -253 |
Summary and key indicators 31 December 2025 | Stage 1 | Stage 2 | Stage 3 | |||
€ million | Not more than 30 DPD | More than 30 DPD | Total | Total | ||
Receivables from customers; on-balance-sheet and off-balance-sheet items | ||||||
Corporate Banking | 32,657 | 2,984 | 253 | 3,238 | 484 | 36,378 |
Loss allowance | ||||||
Corporate Banking | -44 | -70 | -8 | -78 | -130 | -252 |
Coverage ratio, % | ||||||
Corporate Banking | -0.10 | -2.30 | -3.10 | -2.40 | -26.90 | -0.70 |
Receivables from customers; total on-balance-sheet and off-balance-sheet items | 32,657 | 2,984 | 253 | 3,238 | 484 | 36,378 |
Total loss allowance | -44 | -70 | -8 | -78 | -130 | -252 |
Total coverage ratio, % | -0.10 | -2.30 | -3.10 | -2.40 | -26.90 | -0.70 |
Carrying amount, notes and bonds | ||||||
Group Functions | 16,817 | 95 | 95 | 16,912 | ||
Loss allowance | ||||||
Group Functions | -1 | -1 | -1 | -2 | ||
Coverage ratio, % | ||||||
Group Functions | -0.01 | -0.97 | -0.97 | -0.01 | ||
Total notes and bonds | 16,817 | 95 | 95 | 16,912 | ||
Total loss allowance | -1 | -1 | -1 | -2 | ||
Total coverage ratio, % | -0.01 | -0.97 | -0.97 | -0.01 | ||
Exposures | Stage 1 | Stage 2 | Stage 3* | |||
31 December 2024, € million | Not more than 30 DPD | More than 30 DPD | Total | Total exposures | ||
Receivables from customers (gross) | ||||||
Corporate Banking | 25,463 | 2,536 | 289 | 2,825 | 556 | 28,844 |
Total receivables from customers | 25,463 | 2,536 | 289 | 2,825 | 556 | 28,844 |
Off-balance-sheet limits | ||||||
Corporate Banking | 3,542 | 54 | 0 | 55 | 10 | 3,607 |
Total limits | 3,542 | 54 | 0 | 55 | 10 | 3,607 |
Other off-balance-sheet commitments | ||||||
Corporate Banking | 2,638 | 134 | 134 | 32 | 2,804 | |
Total other off-balance-sheet commitments | 2,638 | 134 | 0 | 134 | 32 | 2,804 |
Notes and bonds | ||||||
Group Functions | 13,710 | 124 | 124 | 3 | 13,837 | |
Total notes and bonds | 13,710 | 124 | 0 | 124 | 3 | 13,837 |
Total exposures within the scope of accounting for expected credit losses | 45,353 | 2,848 | 290 | 3,138 | 601 | 49,092 |
On-balance-sheet exposures and related off-balance-sheet limits* | Stage 1 | Stage 2 | Stage 3**** | |||
31 December 2024, € million | Not more than 30 DPD | More than 30 DPD | Total | Total loss allowance | ||
Receivables from customers | ||||||
Corporate Banking | -37 | -66 | -6 | -72 | -148 | -257 |
Total receivables from customers | -37 | -66 | -6 | -72 | -148 | -257 |
Off-balance-sheet commitments** | ||||||
Corporate Banking | -3 | -16 | -16 | -20 | -38 | |
Total off-balance-sheet commitments | -3 | -16 | 0 | -16 | -20 | -38 |
Notes and bonds*** | ||||||
Group Functions | -1 | -1 | -1 | -2 | -4 | |
Total notes and bonds | -1 | -1 | 0 | -1 | -2 | -4 |
Total | -40 | -83 | -6 | -89 | -170 | -300 |
Summary and key indicators 31 December 2024 | Stage 1 | Stage 2 | Stage 3 | |||
Not more than 30 DPD | More than 30 DPD | Total | Total | |||
Receivables from customers; on-balance-sheet and off-balance-sheet items | ||||||
Corporate Banking | 31,643 | 2,724 | 290 | 3,014 | 598 | 35,255 |
Loss allowance | ||||||
Corporate Banking | -39 | -82 | -6 | -88 | -168 | -296 |
Coverage ratio, % | ||||||
Corporate Banking | -0.12 | -3.00 | -2.18 | -2.92 | -28.12 | -0.84 |
Receivables from customers; total on-balance-sheet and off-balance-sheet items | 31,643 | 2,724 | 290 | 3,014 | 598 | 35,255 |
Total loss allowance | -39 | -82 | -6 | -88 | -168 | -296 |
Total coverage ratio, % | -0.12 | -3.00 | -2.18 | -2.92 | -28.12 | -0.84 |
Carrying amount, notes and bonds | ||||||
Group Functions | 13,710 | 124 | 124 | 3 | 13,837 | |
Loss allowance | ||||||
Group Functions | -1 | -1 | -1 | -2 | -4 | |
Coverage ratio, % | ||||||
Group Functions | -0.01 | -1.03 | -1.03 | -62.00 | -0.03 | |
Total notes and bonds | 13,710 | 124 | 124 | 3 | 13,837 | |
Total loss allowance | -1 | -1 | -1 | -2 | -4 | |
Total coverage ratio, % | -0.01 | -1.03 | -1.03 | -62.00 | -0.03 | |
Receivables from customers and off-balance-sheet items, € million | Stage 1 | Stage 2 | Stage 3 | Total |
Receivables from customers; on-balance-sheet and off-balance-sheet items 1 January 2025 | 31,643 | 3,014 | 598 | 35,255 |
Transfers from Stage 1 to Stage 2, incl. repayments | -1,296 | 1,157 | -139 | |
Transfers from Stage 1 to Stage 3, incl. repayments | -41 | 36 | -5 | |
Transfers from Stage 2 to Stage 1, incl. repayments | 303 | -328 | -25 | |
Transfers from Stage 2 to Stage 3, incl. repayments | -191 | 178 | -13 | |
Transfers from Stage 3 to Stage 1, incl. repayments | 18 | -22 | -4 | |
Transfers from Stage 3 to Stage 2, incl. repayments | 43 | -49 | -6 | |
Increases due to origination and acquisition | 7,479 | 192 | 37 | 7,707 |
Decreases due to derecognition | -5,691 | -522 | -236 | -6,449 |
Unchanged Stage, incl. repayments | 242 | -126 | -53 | 63 |
Recognised as final credit loss | 0 | 0 | -4 | -5 |
Receivables from customers; on-balance-sheet and off-balance-sheet items 31 December 2025 | 32,657 | 3,238 | 484 | 36,378 |
Stage 1 | Stage 2 | Stage 3 | Total | |
Receivables from customers and off-balance-sheet items, € million | 12 months | Lifetime | Lifetime | |
Loss allowance 1 January 2025 | 39 | 88 | 168 | 296 |
Transfers from Stage 1 to Stage 2 | -2 | 9 | 7 | |
Transfers from Stage 1 to Stage 3 | 0 | 9 | 8 | |
Transfers from Stage 2 to Stage 1 | 1 | -6 | -5 | |
Transfers from Stage 2 to Stage 3 | -4 | 13 | 9 | |
Transfers from Stage 3 to Stage 1 | 0 | -7 | -7 | |
Transfers from Stage 3 to Stage 2 | 2 | -15 | -13 | |
Increases due to origination and acquisition | 17 | 7 | 17 | 42 |
Decreases due to derecognition | -10 | -24 | -45 | -79 |
Changes in risk parameters (net) | -6 | 8 | -4 | -3 |
Changes in model assumptions and methodology | 4 | -2 | -4 | -1 |
Decrease in allowance account due to write-offs | 0 | 0 | -3 | -3 |
Net change in expected credit losses | 4 | -10 | -38 | -44 |
Loss allowance 31 December 2025 | 44 | 78 | 130 | 252 |
Loss allowance 31 December 2025, € million | OP Corporate Bank |
Loss allowance before management overlays | 231 |
Management overlays | |
Improvement to the processes for the EWS and the identification of groups of connected clients | 5 |
Impact of model adjustments (PMA) included in the risk parameters | 4 |
Impact of PD and SICR model on the existing credit portfolio by new large companies implemented in Q1/2026 | 12 |
Total management overlays | 20 |
Total reported loss allowance | 252 |
Stage 1 | Stage 2 | Stage 3 | Total | |
Notes and bonds, € million | 12 months | Lifetime | Lifetime | |
Loss allowance 1 January 2025 | 1 | 1 | 2 | 4 |
Transfers from Stage 2 to Stage 1 | 0 | 0 | 0 | 0 |
Transfers from Stage 3 to Stage 1 | 0 | 0 | -2 | -2 |
Increases due to origination and acquisition | 0 | 0 | 0 | 0 |
Decreases due to derecognition | 0 | 0 | 0 | 0 |
Changes in risk parameters (net) | 0 | 0 | 0 | 0 |
Net change in expected credit losses | 0 | 0 | -2 | -2 |
Loss allowance 31 December 2025 | 1 | 1 | 0 | 2 |
Receivables from customers and off-balance-sheet items, € million | Stage 1 | Stage 2 | Stage 3 | Total |
Receivables from customers; on-balance-sheet and off-balance-sheet items 1 January 2024 | 31,581 | 3,603 | 761 | 35,945 |
Transfers from Stage 1 to Stage 2, incl. repayments | -1,318 | 1,216 | -102 | |
Transfers from Stage 1 to Stage 3, incl. repayments | -65 | 51 | -14 | |
Transfers from Stage 2 to Stage 1, incl. repayments | 728 | -750 | -22 | |
Transfers from Stage 2 to Stage 3, incl. repayments | -98 | 79 | -19 | |
Transfers from Stage 3 to Stage 1, incl. repayments | 16 | -17 | -1 | |
Transfers from Stage 3 to Stage 2, incl. repayments | 22 | -28 | -5 | |
Increases due to origination and acquisition | 7,041 | 221 | 93 | 7,355 |
Decreases due to derecognition | -5,233 | -1,085 | -287 | -6,605 |
Unchanged Stage, incl. repayments | -1,107 | -115 | -9 | -1,231 |
Recognised as final credit loss | 0 | 0 | -44 | -45 |
Receivables from customers; on-balance-sheet and off-balance-sheet items 31 December 2024 | 31,643 | 3,014 | 598 | 35,255 |
Receivables from customers and off-balance-sheet items, € million | Stage 1 | Stage 2 | Stage 3 | Total |
12 months | Lifetime | Lifetime | ||
Loss allowance 1 January 2024 | 35 | 94 | 196 | 325 |
Transfers from Stage 1 to Stage 2 | -2 | 6 | 0 | 4 |
Transfers from Stage 1 to Stage 3 | 0 | 0 | 9 | 9 |
Transfers from Stage 2 to Stage 1 | 2 | -14 | 0 | -11 |
Transfers from Stage 2 to Stage 3 | 0 | -6 | 18 | 12 |
Transfers from Stage 3 to Stage 1 | 0 | 0 | -4 | -4 |
Transfers from Stage 3 to Stage 2 | 0 | 3 | -5 | -2 |
Increases due to origination and acquisition | 9 | 9 | 30 | 47 |
Decreases due to derecognition | -6 | -20 | -55 | -81 |
Changes in risk parameters (net) | 1 | 16 | 2 | 19 |
Decrease in allowance account due to write-offs | 0 | 0 | -22 | -22 |
Net change in expected credit losses | 4 | -6 | -28 | -30 |
Loss allowance 31 December 2024 | 39 | 88 | 168 | 296 |
Loss allowance 31 December 2024, € million | OP Corporate Bank | |||
Loss allowance before management overlays | 279 | |||
Management overlays | ||||
Bullet and balloon loans | 2 | |||
Improvement to the processes for the EWS and the identification of groups of connected clients | 5 | |||
Climate and environmental risks | 1 | |||
Increase in non-performing exposures and higher probability of default | 8 | |||
Total management overlays | 17 | |||
Total reported loss allowance | 296 |
Notes and bonds, € million | Stage 1 | Stage 2 | Stage 3 | Total |
12 months | Lifetime | Lifetime | ||
Loss allowance 1 January 2024 | 1 | 1 | 1 | 2 |
Transfers from Stage 1 to Stage 2 | 0 | 1 | 0 | 1 |
Increases due to origination and acquisition | 0 | 0 | 2 | 2 |
Decreases due to derecognition | 0 | 0 | -1 | -1 |
Changes in risk parameters (net) | 0 | 0 | 0 | 0 |
Net change in expected credit losses | 0 | 1 | 1 | 2 |
Loss allowance 31 December 2024 | 1 | 1 | 2 | 4 |
31 Dec 2025 | |||||||||||||||
€ million | Balance sheet exposures | Off-balance-sheet exposure, gross | Net exposure after collateral | Loss allowance | |||||||||||
Rating | Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | |||
1 | 329 | 16 | 103 | 270 | 2 | 0 | 0 | ||||||||
2 | 692 | 3,230 | 3,877 | -1 | |||||||||||
3 | 3,600 | 111 | 524 | 13 | 3,265 | 104 | -1 | 0 | |||||||
4 | 4,686 | 40 | 1,160 | 60 | 3,870 | 85 | -2 | -1 | |||||||
5 | 5,514 | 423 | 939 | 41 | 3,252 | 133 | -4 | -2 | |||||||
6 | 4,841 | 540 | 670 | 27 | 2,278 | 123 | -9 | -2 | |||||||
7 | 2,998 | 663 | 242 | 41 | 921 | 245 | -11 | -7 | |||||||
8 | 421 | 329 | 33 | 40 | 93 | 166 | -2 | -17 | |||||||
9 | 46 | 227 | 1 | 11 | 1 | 56 | 0 | -17 | |||||||
10 | 50 | 100 | 1 | 29 | 11 | 37 | -5 | -21 | |||||||
11 | 322 | 27 | 101 | -90 | |||||||||||
12 | 11 | 1 | 9 | -9 | |||||||||||
A | 83 | 14 | 0 | 6 | 0 | 0 | |||||||||
B | 770 | 15 | 4 | 0 | 83 | 0 | 0 | 0 | |||||||
C | 1,327 | 24 | 5 | 0 | 259 | 2 | -1 | 0 | |||||||
D | 679 | 136 | 4 | 0 | 96 | 14 | -2 | -1 | |||||||
E | 150 | 336 | 1 | 0 | 50 | 56 | -3 | -8 | |||||||
F | 123 | 0 | 41 | -32 | |||||||||||
Total | 26,187 | 2,974 | 456 | 6,918 | 263 | 28 | 18,332 | 1,023 | 150 | -44 | -78 | -130 | |||
31 Dec 2024 | |||||||||||||||
€ million | Balance sheet exposures | Off-balance-sheet exposure, gross | Net exposure after collateral | Loss allowance | |||||||||||
Rating | Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | |||
1 | 311 | 24 | 106 | 245 | 23 | 0 | 0 | ||||||||
2 | 570 | 1 | 2,700 | 3,598 | 0 | 0 | |||||||||
3 | 3,469 | 78 | 645 | 2,981 | 61 | -1 | 0 | ||||||||
4 | 4,392 | 31 | 1,023 | 3,374 | 12 | -2 | 0 | ||||||||
5 | 5,739 | 235 | 944 | 22 | 3,639 | 38 | -4 | -1 | |||||||
6 | 4,385 | 352 | 487 | 31 | 1,867 | 140 | -7 | -1 | |||||||
7 | 2,783 | 569 | 229 | 38 | 833 | 244 | -12 | -6 | |||||||
8 | 663 | 774 | 32 | 47 | 122 | 241 | -4 | -20 | |||||||
9 | 34 | 192 | 1 | 16 | 1 | 44 | 0 | -22 | |||||||
10 | 38 | 132 | 0 | 34 | 12 | 49 | -3 | -25 | |||||||
11 | 397 | 40 | 154 | -122 | |||||||||||
12 | 10 | 2 | 8 | -9 | |||||||||||
A | 176 | 0 | 6 | 0 | 45 | 0 | -1 | -1 | |||||||
B | 907 | 19 | 4 | 0 | 141 | 0 | -1 | -1 | |||||||
C | 1,383 | 32 | 2 | 0 | 202 | 5 | -1 | -1 | |||||||
D | 473 | 132 | 1 | 0 | 100 | 19 | -2 | -2 | |||||||
E | 139 | 253 | 0 | 0 | 36 | 49 | -3 | -8 | |||||||
F | 148 | 0 | 47 | -37 | |||||||||||
Total | 25,463 | 2,825 | 556 | 6,180 | 189 | 42 | 17,196 | 928 | 209 | -39 | -88 | -168 | |||
Macroeconomic variable | Scenario | Average (%) | Minimum (%) | Maximum (%) |
GDP growth | Downside | -0.2 | -0.8 | 1.0 |
Baseline | 1.4 | 1.0 | 2.0 | |
Upside | 2.7 | 1.0 | 4.4 | |
Unemployment, % | Downside | 9.2 | 8.3 | 9.7 |
Baseline | 8.3 | 7.0 | 9.5 | |
Upside | 7.6 | 6.0 | 9.5 | |
House price index | Downside | 0.8 | 0.0 | 1.9 |
Baseline | 2.2 | 0.0 | 3.0 | |
Upside | 3.4 | 0.0 | 5.5 | |
12-month Euribor where the effect of GDP growth and inflation has been deducted | Downside | 0.5 | 0.3 | 1.0 |
Baseline | 1.4 | 1.1 | 1.8 | |
Upside | 2.5 | 1.5 | 3.3 | |
3-month real interest rate | Downside | 0.1 | -0.3 | 0.8 |
Baseline | 0.6 | 0.2 | 0.9 | |
Upside | 1.2 | 0.3 | 2.2 |
Macroeconomic variable | Scenario | Average (%) | Minimum (%) | Maximum (%) |
GDP growth | Downside | -0.4 | 0.0 | -0.5 |
Baseline | 1.4 | 1.3 | 2.0 | |
Upside | 2.9 | 2.3 | 3.9 | |
Unemployment, % | Downside | 8.1 | 7.9 | 8.2 |
Baseline | 7.1 | 6.5 | 7.9 | |
Upside | 6.5 | 5.7 | 7.7 | |
House price index | Downside | 1.2 | 1.0 | 1.4 |
Baseline | 2.8 | 2.8 | 2.8 | |
Upside | 4.0 | 3.8 | 4.1 | |
12-month Euribor where the effect of GDP growth and inflation has been deducted | Downside | 0.1 | -0.3 | 1.4 |
Baseline | 1.2 | 1.0 | 1.4 | |
Upside | 2.3 | 1.7 | 3.0 | |
3-month real interest rate | Downside | -0.1 | -0.7 | 1.4 |
Baseline | 0.5 | 0.1 | 0.8 | |
Upside | 1.0 | 0.3 | 1.7 |
The table below shows loss allowance regarding significant receivables under various scenarios by impairment stage on 31 December 2025. | ||||
Total loss allowances of corporate and household customers, € million | Weighted loss allowance | Loss allowance under downside scenario | Loss allowance under baseline scenario | Loss allowance under upside scenario |
Stage 1* | -43 | -45 | -43 | -41 |
Stage 2* | -73 | -76 | -72 | -70 |
Stage 3* | -123 | -131 | -123 | -116 |
Total | -239 | -252 | -238 | -227 |
The table below shows loss allowance regarding significant receivables under various scenarios by impairment stage on 31 December 2024. | ||||
Total loss allowances of corporate and household customers, € million | Weighted loss allowance | Loss allowance under downside scenario | Loss allowance under baseline scenario | Loss allowance under upside scenario |
Stage 1* | -36 | -34 | -32 | -30 |
Stage 2* | -81 | -82 | -79 | -78 |
Stage 3* | -162 | -172 | -161 | -152 |
Total | -278 | -288 | -272 | -259 |
Group Stage | Loss allowance 31 December 2025 | Loss allowance sensitivity analysis* | Relative Change, % |
Households | |||
Stage 1 | -6 | -6 | 3.5 |
Stage 2 | -8 | -9 | 15.1 |
Stage 3 | -32 | -32 | 0.0 |
Corporate customers | |||
Stage 1 | -32 | -35 | 8.0 |
Stage 2 | -65 | -69 | 6.2 |
Stage 3 | -91 | -92 | 1.7 |
Total | -234 | -243 | 4.2 |
The table below shows the sensitivity of change in the loss allowance of the groups' household and corporate customers on 31 December 2024, when the economic situation weakens due to changes in the combined effects of interest rates, investment growth rate and GDP. | |||
Group Stage | Loss allowance 31 December 2024 | Loss allowance sensitivity analysis* | Relative Change, % |
Households | |||
Stage 1 | -5 | -5 | 1.8 |
Stage 2 | -8 | -9 | 14.6 |
Corporate customers | |||
Stage 1 | -31 | -33 | 7.0 |
Stage 2 | -75 | -83 | 10.2 |
Total | -119 | -130 | 9.4 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Collateral given on behalf of own liabilities and commitments | 1,404 | 1,558 |
Total collateral given* | 1,404 | 1,558 |
Secured derivative liabilities | 467 | 729 |
Other secured liabilities | 879 | 759 |
Total | 1,346 | 1,489 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Guarantees | 245 | 191 |
Guarantee liabilities | 2,104 | 2,178 |
Loan commitments | 5,579 | 5,238 |
Commitments related to short-term trade transactions | 313 | 291 |
Other | 478 | 478 |
Total off-balance-sheet commitments | 8,720 | 8,376 |
€ million | 31 Dec 2025 | 31 Dec 2024 |
Fair value of collateral received | ||
Derivatives | 747 | 990 |
Total | 747 | 990 |
Fair value of assets 31 December 2025, € million | Level 1 | Level 2 | Level 3 | Total |
Financial assets recognised at fair value through profit or loss | ||||
Equity instruments | 0 | 2 | 1 | 3 |
Debt instruments | 241 | 110 | 39 | 390 |
Derivative contracts | 0 | 2,423 | 121 | 2,544 |
Recognised at fair value through other comprehensive income | ||||
Equity instruments | 0 | 0 | 0 | 0 |
Debt instruments | 11,804 | 2,429 | 662 | 14,895 |
Total financial instruments | 12,046 | 4,964 | 823 | 17,832 |
Fair value of assets 31 December 2024, € million | Level 1 | Level 2 | Level 3 | Total |
Financial assets recognised at fair value through profit or loss | ||||
Equity instruments | 0 | 3 | 1 | 4 |
Debt instruments | 83 | 103 | 41 | 227 |
Derivative contracts | 3 | 3,284 | 96 | 3,383 |
Recognised at fair value through other comprehensive income | ||||
Equity instruments | 0 | 0 | 0 | 0 |
Debt instruments | 4,273 | 7,297 | 606 | 12,176 |
Total financial instruments | 4,360 | 10,688 | 744 | 15,791 |
Fair value of liabilities 31 December 2025, € million | Level 1 | Level 2 | Level 3 | Total |
Financial liabilities recognised at fair value through profit or loss | ||||
Structured notes | 0 | 0 | 1,804 | 1,804 |
Other | 0 | 21 | 0 | 21 |
Derivative contracts | 0 | 2,612 | 35 | 2,647 |
Total | 0 | 2,633 | 1,840 | 4,473 |
Fair value of liabilities 31 December 2024, € million | Level 1 | Level 2 | Level 3 | Total |
Financial liabilities recognised at fair value through profit or loss | ||||
Structured notes | 0 | 0 | 2,201 | 2,201 |
Other | 0 | 2 | 0 | 2 |
Derivative contracts | 0 | 3,076 | 74 | 3,150 |
Total | 0 | 3,078 | 2,275 | 5,353 |
Financial assets, € million | Recognised at fair value through profit or loss | Derivative contracts | Recognised at fair value through other comprehensive income | Total assets |
Opening balance 1 January 2025 | 42 | 96 | 606 | 744 |
Total gains/losses in profit or loss | -36 | 24 | 0 | -12 |
Transfers to Level 3 | 35 | 0 | 232 | 267 |
Transfers from Level 3 | 0 | 0 | -176 | -176 |
Closing balance 31 December 2025 | 40 | 121 | 662 | 823 |
Financial assets, € million | Recognised at fair value through profit or loss | Derivative contracts | Recognised at fair value through other comprehensive income | Total assets |
Opening balance 1 January 2024 | 36 | 98 | 728 | 862 |
Total gains/losses in profit or loss | -32 | -2 | 0 | -34 |
Transfers to Level 3 | 37 | 0 | 174 | 211 |
Transfers from Level 3 | 0 | 0 | -296 | -296 |
Closing balance 31 December 2024 | 42 | 96 | 606 | 744 |
Financial liabilities, € million | Recognised at fair value through profit or loss | Derivative contracts | Total liabilities |
Opening balance 1 January 2025 | 2,201 | 74 | 2,275 |
Total gains/losses in profit or loss | 148 | -39 | 109 |
Issues | 368 | 368 | |
Redemptions and repurchases | -832 | -832 | |
Other changes | -81 | -81 | |
Closing balance 31 December 2025 | 1,804 | 35 | 1,840 |
Financial liabilities, € million | Recognised at fair value through profit or loss | Derivative contracts | Total liabilities |
Opening balance 1 January 2024 | 2,487 | 91 | 2,578 |
Total gains/losses in profit or loss | 93 | -17 | 76 |
Issues | 714 | 0 | 714 |
Redemptions and repurchases | -1,037 | 0 | -1,037 |
Other changes | -56 | 0 | -56 |
Closing balance 31 December 2024 | 2,201 | 74 | 2,275 |
€ million | Net investment income | Net gains/losses on assets and liabilities held at year end |
Total net income | -121 | -121 |
€ million | Net investment income | Net gains/losses on assets and liabilities held at year end |
Total net income | -110 | -110 |
Type of instrument, € million | Receivables | Liabilities | Net balance | Effect on the income statement | Plausible change in fair value (%) |
Recognised at fair value through profit or loss | |||||
Structured notes** | 1,804 | 1,804 | 7 | 0.4 | |
Private equity funds* | 39 | 39 | 4 | 10.0 | |
Real estate funds*** | 1 | 1 | 0 | 20.0 | |
Derivatives | |||||
Derivatives hedging structured notes** | 121 | -35 | 86 | 7 | 8.0 |
Recognised at fair value through profit or loss | |||||
Bond investments | 662 | 662 | 66 | 10.0 |
Type of instrument, € million | Receivables | Liabilities | Net balance | Effect on the income statement | Plausible change in fair value (%) |
Recognised at fair value through profit or loss | |||||
Structured notes** | 2,201 | 2,201 | 2 | 0.1 | |
Private equity funds* | 41 | 41 | 4 | 10.0 | |
Real estate funds*** | 1 | 1 | 0 | 20.0 | |
Derivatives | |||||
Derivatives hedging structured notes** | 96 | -74 | 22 | 2 | 11.0 |
Recognised at fair value through profit or loss | |||||
Bond investments | 606 | 606 | 61 | 10.0 |
Financial assets | Financial assets not set off in the balance sheet | |||||
31 December 2025, € million | Gross amount of financial assets | Gross amount of financial liabilities deducted from financial assets* | Net amount presented in the balance sheet | Master agreements** | Collateral given | Net amount |
Derivatives | 2,544 | 2,544 | -1,071 | -747 | 726 | |
31 December 2024, € million | ||||||
Derivatives | 3,384 | 3,384 | -1,752 | -990 | 642 | |
Financial liabilities | Financial liabilities not set off in the balance sheet | |||||
31 December 2025, € million | Gross amount of financial liabilities | Gross amount of financial assets deducted from financial liabilities* | Net amount presented in the balance sheet | Master agreements** | Collateral given | Net amount |
Derivatives | 2,647 | 2,647 | -1,071 | -173 | 1,404 | |
31 December 2024, € million | ||||||
Derivatives | 3,150 | 3,150 | -1,752 | -371 | 1,027 | |
Credit risks | The debtor is unable to meet their repayment obligations under the agreement, either temporarily or permanently. In the case of credit risk, the amount of actual credit losses deviate from the expected amount. |
Liquidity risks | Liquidity risk is caused by the timing of inflowing or outgoing cashflows (payments) and/or imbalances between them. A balance sheet shrinks during a certain period as more funds are withdrawn than expected, or market transactions cannot be executed in the accustomed quantities and terms. Insufficiently available liquidity or capital, and larger expenses than expected, prevent business goals from being realised as presented in the strategy. |
Structural interest rate risk | The banking book consists of non-trading book customer agreements (loans and deposits), market-based funding, equity capital, liquidity buffer (fixed income investments and cash) and interest rate derivatives (items that balance risks and liquidity). In the insurance companies, net interest income comprises technical provisions, interest rate-sensitive investments and interest rate derivatives used to manage interest rate risk. Adverse interest rate movements have a negative impact on Banking's annual net interest income, and on the insurance company's earnings (IFRS 17) and solvency. |
Other market risks | Price changes observable on financial markets. Market risk materialises when value changes more than expected, due to a risk exposure. Greater losses than expected are realised at portfolio level. |
Counterparty risks | Counterparty risk may arise from a contracting partner's finances, a deterioration in a counterparty's creditworthiness or solvency, changes in market value, or insufficient collateral. For the above-mentioned reasons, the counterparty fails to meet its financial obligations to OP Pohjola. Counterparty risk can lead to financial losses and additional costs. |
Operational risks | Operational risk concerns daily operations. Internal causes under OP Pohjola's control include poor-quality operating processes, deficiencies in staff competencies and conduct, or information systems that fail to adequately support operations and the related controls. However, disruptions or errors in daily operations can also be caused by external events beyond OP Pohjola's control. Operational risk can materialise in the form of various adverse consequences, such as additional costs, loss of earnings and customers, poor decision-making due to a false situational picture, operational stoppages and erosion of trust. Operational risk is closely related to other risks. |
Compliance risks | Causes include inadequate operating-process quality, involving deficiencies in guidelines and governance structures, in staff competencies and moral conduct, and in controls supporting processes. Due to the aforementioned causes, daily operations do not comply with regulations and internal guidelines. Compliance risk can materialise as penalties, operational restrictions or additional regulatory requirements imposed by a regulator. |
Model risks | Model risk occurs when a model created to describe a certain phenomenon or behaviour fails to do so in the intended manner. In such cases, model outcomes may lead to flawed assessments, and decisions based on such outcomes may cause financial losses or reputational damage. |
Business model risk | Poor strategic choices or changes in the business environment. Lack of reaction or of flexibility in the business and competitive environment, or changes in customers' values or technology. Impacts may include additional costs and lost earnings and customer relationships. |
Risk of implementing strategic guidelines | Causes may include insufficient quality of processes and development tools, or gaps in the competencies and moral conduct of management and staff. This risk materialises when strategic projects do not proceed as expected. This leads to schedule overruns, budget overruns or project deliverables that do not meet the set goals. |
€ million | 2021 | 2022 | 2023 | 2024 | 2025 |
Receivables written down as loan and guarantee losses | -46 | -86 | -42 | -29 | -14 |
Payments on receivables written down | 1 | 1 | 1 | 1 | 1 |
Expected credit losses (ECL) on receivables from customers and off-balance-sheet items | -28 | 68 | -55 | 29 | 44 |
Expected credit losses (ECL) on notes and bonds | 0 | 0 | 0 | -2 | 2 |
Total | -74 | -18 | -96 | -1 | 32 |
€ million | 31 Dec 2025 | % | 31 Dec 2024 | % |
Object of financing as collateral | 4,980 | 32.6 | 4,972 | 33.9 |
Property or lease mortgage on office or industrial property | 3,841 | 25.2 | 3,531 | 24.1 |
Public-sector guarantees | 2,225 | 14.6 | 1,984 | 13.5 |
Shares and participations, other | 1,491 | 9.8 | 1,648 | 11.2 |
Shares in housing corporations, and housing associations and property companies in residential use | 1,336 | 8.8 | 1,070 | 7.3 |
Property or lease mortgage on residential property | 358 | 2.3 | 501 | 3.4 |
Business mortgage | 208 | 1.4 | 252 | 1.7 |
Other collateral | 482 | 3.2 | 383 | 2.6 |
Factoring | 175 | 1.1 | 170 | 1.2 |
Bank guarantee | 158 | 1.0 | 136 | 0.9 |
Total | 15,254 | 100.0 | 14,646 | 100.0 |
€ million | 31 Dec 2025 | % | 31 Dec 2024 | % |
Liabilities to credit institutions | 27,745 | 42.4 | 25,049 | 38.4 |
Financial liabilities recognised at fair value through profit or loss* | 1,804 | 2.8 | 2,201 | 3.4 |
Liabilities to customers | ||||
Deposits | 17,000 | 26.0 | 17,166 | 26.3 |
Other | 2,721 | 4.2 | 2,221 | 3.4 |
Debt securities issued to the public | ||||
Certificates of deposit, commercial papers and ECPs (Euro Commercial Papers) | 4,579 | 7.0 | 4,621 | 7.1 |
Bonds* | 7,196 | 11.0 | 8,939 | 13.7 |
Subordinated bonds (SNP) | 3,621 | 5.5 | 3,566 | 5.5 |
Subordinated liabilities | 811 | 1.2 | 1,444 | 2.2 |
Total | 65,477 | 100.0 | 65,207 | 100.0 |
31 December 2025, € million | Undivided | Less than 3 months | 3–12 months | 1–5 yrs | 5–10 yrs | More than 10 years | Total |
Financial assets | |||||||
Cash and cash equivalents | 15,769 | 15,769 | |||||
Receivables from credit institutions | 1,609 | 1,765 | 7,684 | 11,058 | |||
Receivables from customers | 3,896 | 4,992 | 19,729 | 1,303 | 1,913 | 31,833 | |
Investment assets | 486 | 526 | 10,324 | 6,288 | 4 | 17,627 | |
Derivatives | 2,538 | 1 | 3 | 0 | 1 | 2,544 | |
Total financial assets | 2,538 | 21,762 | 7,285 | 37,737 | 7,591 | 1,918 | 78,831 |
Financial liabilities | Undivided | Less than 3 months | 3–12 months | 1–5 yrs | 5–10 yrs | More than 10 years | Total |
Liabilities to credit institutions | 15,398 | 1,628 | 10,180 | 548 | 27,754 | ||
Liabilities to customers | 19,721 | 0 | 19,722 | ||||
Debt securities issued to the public | 2,529 | 4,227 | 9,583 | 861 | 1 | 17,201 | |
Subordinated liabilities | 811 | 811 | |||||
Derivatives | 2,530 | 11 | 14 | 66 | 28 | 2,647 | |
Total financial liabilities | 2,530 | 37,659 | 6,680 | 19,828 | 1,437 | 1 | 68,135 |
Guarantees | 245 | 245 | |||||
Guarantee liabilities | 274 | 495 | 671 | 623 | 42 | 2,104 | |
Loan commitments | 5,579 | 5,579 | |||||
Commitments related to short-term trade transactions | 27 | 220 | 66 | 313 | |||
Other | 478 | 478 | |||||
Total off-balance-sheet commitments | 0 | 6,603 | 715 | 737 | 623 | 42 | 8,720 |
31 December 2024, € million | Undivided | Less than 3 months | 3–12 months | 1–5 yrs | 5–10 yrs | More than 10 years | Total |
Financial assets | |||||||
Cash and cash equivalents | 18,074 | 18,074 | |||||
Receivables from credit institutions | 1,674 | 1,451 | 8,011 | 240 | 11,377 | ||
Receivables from customers | 3,841 | 4,239 | 20,476 | 982 | 1,840 | 31,378 | |
Investment assets | 450 | 343 | 8,356 | 4,974 | 0 | 14,123 | |
Derivatives | 3,283 | 53 | 16 | 29 | 2 | 3,383 | |
Total financial assets | 3,283 | 24,092 | 6,049 | 36,872 | 6,198 | 1,840 | 78,335 |
Financial liabilities | Undivided | Less than 3 months | 3–12 months | 1–5 yrs | 5–10 yrs | More than 10 years | Total |
Liabilities to credit institutions | 12,740 | 1,311 | 10,216 | 1,460 | 25,727 | ||
Liabilities to customers | 19,002 | 381 | 19,384 | ||||
Debt securities issued to the public | 2,417 | 6,586 | 9,433 | 726 | 84 | 19,246 | |
Subordinated liabilities | 1,445 | 1,445 | |||||
Derivatives | 3,061 | 0 | 7 | 64 | 14 | 4 | 3,150 |
Total financial liabilities | 3,061 | 34,159 | 9,731 | 19,713 | 2,200 | 88 | 68,951 |
Guarantees | 191 | 191 | |||||
Guarantee liabilities | 283 | 512 | 694 | 644 | 44 | 2,178 | |
Loan commitments | 5,238 | 5,238 | |||||
Commitments related to short -term trade transactions | 61 | 169 | 61 | 291 | |||
Other | 478 | 478 | |||||
Total off-balance-sheet commitments | 0 | 6,252 | 681 | 756 | 644 | 44 | 8,376 |
Table 1 Effect on projected net interest income | 1 pp parallel rise | 1 pp parallel fall | 0.5 pp parallel rise | 0.5 pp parallel fall |
31 Dec 2025 | 17 | -17 | 8 | -9 |
31 Dec 2024 | 22 | -22 | 11 | -11 |
Table 2 Effect on reported equity | 1 pp parallel rise | 1 pp parallel fall | 0.5 pp parallel rise | 0.5 pp parallel fall |
31 Dec 2025 | -31 | 28 | -15 | 14 |
31 Dec 2024 | -20 | 18 | -10 | 9 |
Table 3 Effect on value of long-term investment assets | 1 pp rise | 1 pp fall | 0.5 pp rise | 0.5 pp fall |
31 Dec 2025 | -657 | 657 | -329 | 329 |
31 Dec 2024 | -540 | 540 | -270 | 270 |
Year(s) | 0−1 | 1−3 | 3−5 | 5−7 | 7−10 | 10− | Total | % |
Aaa* | 15,833 | 3,697 | 3,762 | 2,869 | 1,115 | 0 | 27,276 | 82.8% |
Aa1−Aa3 | 59 | 807 | 842 | 765 | 370 | 0 | 2,842 | 8.6% |
A1−A3 | 71 | 176 | 166 | 150 | 69 | 4 | 635 | 1.9% |
Baa1−Baa3 | 52 | 702 | 452 | 28 | 17 | 1 | 1,251 | 3.8% |
Ba1 or lower | 11 | 23 | 15 | 3 | 51 | 0.2% | ||
Internally rated | 466 | 57 | 9 | 299 | 51 | 882 | 2.7% | |
Total | 16,491 | 5,462 | 5,245 | 4,113 | 1,621 | 4 | 32,937 | 100.0% |
Year(s) | 0−1 | 1−3 | 3−5 | 5−7 | 7−10 | 10− | Total | % |
Aaa* | 18,230 | 2,845 | 3,652 | 2,006 | 1,086 | 27,818 | 87.0% | |
Aa1−Aa3 | 1 | 619 | 708 | 431 | 386 | 0 | 2,145 | 6.7% |
A1−A3 | 22 | 24 | 6 | 8 | 1 | 0 | 61 | 0.2% |
Baa1−Baa3 | 31 | 599 | 573 | 46 | 1 | 0 | 1,250 | 3.9% |
Ba1 or lower | 0 | 10 | 20 | 30 | 0.1% | |||
Internally rated | 356 | 84 | 42 | 198 | 681 | 2.1% | ||
Total | 18,641 | 4,180 | 5,001 | 2,689 | 1,474 | 0 | 31,985 | 100.0% |
2025 | ||
Name | Domicile | |
OP Corporate Bank plc Estonian Branch | Branch | Estonia |
OP Corporate Bank plc Latvian Branch | Branch | Latvia |
OP Corporate Bank plc Lithuanian Branch | Branch | Lithuania |
Financial information on 31 December 2025, € million | Estonia | Latvia | Lithuania | Total |
Total operating income | 51 | 50 | 80 | 181 |
Total EBIT | 17 | 9 | 22 | 49 |
Total current tax | 2 | 2 | 3 | 8 |
Total personnel in person-years | 42 | 42 | 60 | 144 |
2024 | ||
Name | Domicile | |
OP Corporate Bank plc Estonian Branch | Branch | Estonia |
OP Corporate Bank plc Latvian Branch | Branch | Latvia |
OP Corporate Bank plc Lithuanian Branch | Branch | Lithuania |
Financial information on 31 December 2024, € million | Estonia | Latvia | Lithuania | Total |
Total operating income | 64 | 60 | 95 | 219 |
Total EBIT | 7 | 8 | 14 | 30 |
Total current tax | 2 | 2 | 3 | 7 |
Total personnel in person-years | 44 | 43 | 58 | 145 |
Related party transactions 2025 | |||
€ thousand | Parent company | Key management personnel | Other* |
Loans | 429,531 | 234 | 1,946,630 |
Other receivables | 0 | 783,786 | |
Deposits | 1,079,344 | 1,777,253 | |
Other liabilities | 3,089 | 108,271 | |
Interest income | 17,106 | 8 | 215,744 |
Interest expenses | -29,521 | -30,979 | |
Commission income | 400 | 13 | 5,788 |
Commission expenses | -3,531 | 0 | -1,666 |
Net investment income | -34,996 | ||
Other operating income | 1,628 | 13,360 | |
Operating expenses | -122,725 | -15,580 | |
Contingent liabilities and derivatives | |||
Off-balance-sheet commitments | |||
Guarantee liabilities | 326,878 | ||
Derivative contracts | |||
Fair value, assets | 108,601 | ||
Fair value, liabilities | 464,401 | ||
Salaries and other short-term benefits, and performance-based pay | |||
Wages and salaries | 736 | ||
Related party holdings | |||
Number of shares | 319,551,415 |
Related party transactions 2024 | |||
€ thousand | Parent company | Key management personnel | Other* |
Loans | 572,894 | 197 | 1,959,530 |
Other receivables | 21 | 920,658 | |
Deposits | 1,663,656 | 1,597,587 | |
Other liabilities | 2,272 | 117,955 | |
Interest income | 34,712 | 10 | 517,222 |
Interest expenses | -48,926 | -46,774 | |
Commission income | 423 | 2 | 5,763 |
Commission expenses | -1,738 | -1 | -1,505 |
Net investment income | -11,053 | ||
Other operating income | 16 | 11,238 | |
Operating expenses | -112,241 | -20,326 | |
Off-balance-sheet commitments | |||
Guarantee liabilities | 301,457 | ||
Derivative contracts | |||
Fair value, assets | 116,502 | ||
Fair value, liabilities | 588,132 | ||
Salaries and other short-term benefits, and performance-based pay | |||
Wages and salaries | 671 | ||
Related party holdings | |||
Number of shares | 319,551,415 |
€ thousand | 2025 | 2024 |
Pension costs of defined contribution plans under TyEL | 679 | 608 |
IFRS expense of voluntary supplementary pension | 5 | 11 |
Pension obligation of voluntary supplementary pension | 1,086 | 900 |
Pension costs of supplementary defined contribution plans | 92 | 91 |
Balance sheet, € million | 31 Dec 2025 | 31 Dec 2024 |
Derivative contracts (assets) | 270 | 320 |
Derivative contracts (liabilities) | 567 | 720 |
Receivables from credit institutions | 7,080 | 7,430 |
Liabilities to credit institutions | 27,026 | 24,339 |
Debt securities issued to the public | 107 | 249 |
Income statement, € million | Q1–4/2025 | Q1–4/2024 |
Interest income | 203 | 233 |
Interest expenses | -568 | -737 |
Commission income | 3 | 3 |
Commission expenses | -41 | -42 |
Other income | 34 | 20 |
Timo Ritakallio Chair of the Board of Directors | Katja Keitaanniemi CEO | |||
Mikko Timonen Board member | Petteri Rinne Board member | |||
Olli Lehtilä Board member | Mika Kivimäki Board member | |||
Hannakaisa Länsisalmi Board member |
Materiality • Overall materiality: 75 million euro | |
Key Audit Matters • Expected credit losses • Certain Level 2 and 3 instruments measured at fair value • General IT controls supporting financial reporting | |
Overall materiality | 75 million euro |
How we determined it | Approximately 0,1 percent of total assets |
Rationale for the materality benchmark applied | We selected total assets as the benchmark for determining materiality because, in our view, it is an appropriate benchmark for assessing OP Corporate Bank Plc's financial position and performance. Additionally, total assets is a generally accepted benchmark. We chose to apply a percentage of approximately 0,1 percent, which is within the range of acceptable quantitative materiality thresholds in auditing standards. |
Key audit matter in the audit | How our audit addressed the key audit matter |
Expected credit losses | |
See notes to the financial statements 1 and 5 | |
Expected credit losses ("ECL") are primarily calculated using a system-based method that applies the probability of default/loss given default approach (PD/LGD method) on a contract-by-contract basis for all personal and corporate customer exposures. | Our audit procedures included both control testing and substantive testing. We also assessed the accounting principles related to the calculation and recording of ECL against the requirements of the IFRS 9 standard. |
In the ECL calculation, contracts are classified into three different stages, reflecting the deterioration of credit quality since the initial recognition. For Stage 1 contracts, the credit risk has not increased significantly since the original recognition, and a 12-month ECL is calculated for them. For Stage 2 contracts, the credit risk has increased significantly since the original recognition, and a lifetime ECL is calculated for them. Stage 3 contracts consist of non- performing contracts, for which a lifetime ECL is also calculated. In addition to the system-based ECL calculation, an expert judgment-based ECL calculation method is used for the largest exposures that have reached Stage 2 or 3. | We obtained an understanding of the processes for loan origination, credit risk management, collateral management, and the calculation of expected credit losses, and we evaluated the key controls of these processes. We tested the effectiveness of selected controls to obtain audit evidence. Our risk modeling experts assessed the methodology, input data, and assumptions used in the credit loss modeling. We verified that the implementation of new models was carried out appropriately. |
Management also makes additional loss allowances based on its judgment to account for uncertainties and risks related to the current and future operating environment that the ECL calculation model does not consider or to correct the limitations of the ECL calculation model. | We evaluated the appropriateness of forward-looking information and examined the internal controls related to the preparation of macroeconomic forecasts. |
Key audit matter in the audit | How our audit addressed the key audit matter |
Additional provisions are made both directly to the amount of the loss allowance and to the risk parameters used in the ECL models. | We assessed the additional loss allowances based on management's judgment. We examined the assumptions based on management's judgment and the input data used in the calculation of additional provisions. |
Expected credit losses are a key audit matter due to the complex ECL calculation methods and the management judgment involved in the estimates and assumptions used. | We conducted a risk-based review of credit loss allowances based on expert assessments and evaluated the appropriateness of credit analyses and calculations. |
This matter is a significant risk of material misstatement referred to in Article 10(2c) of Regulation (EU) No 537/2014. | |
Certain Level 2 and 3 instruments measured at fair value | |
See notes to the financial statements 14 and 18 | |
The proportion of financial assets and liabilities measured at fair value on OP Corporate Bank Plc’s balance sheet is significant, and the valuations of financial instruments at fair value hierarchy levels 2 and especially 3 are primarily based on internal valuation methods and unobservable inputs, which involve management judgment. | We obtained an understanding of the valuation process for financial instruments and evaluated the design and effectiveness of controls and the appropriateness of valuation models used. We evaluated the appropriateness of the accounting principles and valuation methods related to financial instruments. |
Changes in market conditions have a significant impact on the fair value of financial instruments. Important areas of financial instrument valuation include the frameworks and principles of valuation and valuation models, as well as controls related to fair value price verification, the accuracy of the data used, fair value adjustments, fair value hierarchy levels, and the management and monitoring of valuation models. | We tested the accuracy of the valuation of financial instruments by performing an independent valuation of significant balance sheet items of the OP Corporate Bank Plc and assessed the appropriateness of the assumptions and management estimates applied in the valuations. |
Key audit matter in the audit | How our audit addressed the key audit matter |
General IT controls supporting financial reporting | |
OP Corporate Bank Plc's operations, internal control environment, and financial reporting rely on numerous IT systems. The volume of transactions affecting financial reporting is large, and IT systems support automated accounting and reconciliation procedures across various processes. | We obtained an understanding of the IT environment related to OP Corporate Bank Plc's financial reporting and the controls relevant to the audit. |
Effectively functioning general IT controls help ensure the accuracy of the information produced by applications. Effective general IT controls are also a prerequisite for the functioning of automated controls and automated accounting procedures, as well as for our audit approach. To ensure the completeness and accuracy of data, it is important that the management and monitoring of access rights, changes to systems, software development, and IT operations are properly designed and operate effectively. | Our audit procedures included evaluating the design and testing the operational effectiveness of controls relevant to financial reporting IT systems and performing substantive testing. Our procedures included general IT controls over user access management, change management, software development management, and IT operations management. |
General IT controls that support financial reporting constitute a key audit matter due to the complexity of the system environment and our audit approach. | In terms of user access management, the audit procedures included testing the addition and removal of user rights, appropriate monitoring, and segregation of duties. Other key areas tested were the monitoring, testing, and approval of changes made to IT systems, as well as controls related to the development, acquisition, and implementation process of systems in software development, and IT operations, such as the scheduling and monitoring of batch processing for financial reporting. |